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ABSTRACT: The total syntheses of 12-epoxyobtusallene IV,
12-epoxyobtusallene II, obtusallene X, marilzabicycloallene C,
and marilzabicycloallene D as halogenated C15-acetogenin 12-
membered bicyclic and tricyclic ether bromoallene-containing
marine metabolites from Laurencia species are described. Two
enantiomerically pure C4-epimeric dioxabicyclo[8.2.1]-
tridecenes were synthesized by E-selective ring-closing meta-
thesis where their absolute stereochemistry was previously set
via catalytic asymmetric homoallylic epoxidation and elabo-
rated via regioselective epoxide-ring opening and diastereose-
lective bromoetheriﬁcation. Epimeric face-selective oxidation
of their Δ12,13 oleﬁns followed by bromoallene installation
allowed access to the oppositely conﬁgured 12,13-epoxides of
12-epoxyobtusallene II and 12-epoxyobtusallene IV. Subsequent exploration of their putative biomimetic oxonium ion
formation−fragmentations reactions revealed diastereodivergent pathways giving marilzabicycloallene C and obtusallene X,
respectively. The original conﬁgurations of the substrates evidently control oxonium ion formation and their subsequent
preferred mode of fragmentation by nucleophilic attack at C9 or C12. Quantum modeling of this stereoselectivity at the ωB97X-
D/Def2-TZVPPD/SCRF = methanol level revealed that in addition to direction resulting from hydrogen bonding, the dipole
moment of the ion-pair transition state is an important factor. Marilzabicycloallene D as a pentahalogenated 12-membered
bicyclic ether bromoallene was synthesized by a face-selective chloronium ion initiated oxonium ion formation−fragmentation
process followed by subsequent bromoallene installation.
■ INTRODUCTION
Since the ﬁrst report in the 1960s,1 red algae of the family
Rhodomelaceae, in particular of the genus Laurencia, have been
found to give rise to fascinating structurally diverse non-
terpenoid C15-acetogenin (ACG) metabolites as halogenated
monocyclic, bicyclic, and tricyclic ring ethers2,3 where these
metabolites can be usefully classiﬁed on the basis of the largest
ether ring size present.4 These complex structures have
attracted much attention as synthetic target molecules,5,6 and
recent further eﬀorts have also been directed at further
elucidating7 and unifying8 their biosynthetic origins. The
largest reported ether ring sizes in these C15-ACGs are those
compounds with 12-membered ether rings: the obtusal-
lenes9−15 and the more recently discovered marilzabicycloal-
lenes.16
Despite much synthetic eﬀort in the wider family, the total
synthesis of any of these 12-membered cyclic ethers remains
unreported. Obtusallene II (1) (Figure 1A) is considered to be
the biogenetic precursor to the other obtusallenes and is,
therefore, an interesting synthetic target.17 What is more,
obtusallenes II and IV (2), related as C4-epimers (C15-ACG
numbering) and as enantiomeric R and S bromoallenes,
respectively, have been hypothesized as the biogenetic
precursors to marilzabicycloallenes A−D (3−6) (Figure 1A)
via 12S,13S-conﬁgured onium ions A (X = OH, Cl; R =
−CHCCHBr) and, hence, 12R-conﬁgured oxonium ions
B in transannular oxonium ion formation−fragmentations with
attack of the nucleophile at C9 (Figure 1B).
16,18 Recently
reported15 12R,13R-conﬁgured coisolates 12-epoxyobtusallene
IV (7) and obtusallene X (8) are therefore evidently related
metabolites (Figure 1C). Epoxide 7 is clearly related to oleﬁn 2
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by epoxidation of the Re face of the macrocyclic oleﬁn.19 On
the basis of their absolute conﬁgurations at C12 and C13, we
propose that obtusallene X (8) arises biogenetically from 12-
epoxyobtusallene IV (7) via diastereomeric 12S-oxonium ion B′
in a transannular oxonium ion formation−fragmentation with a
diastereodivergent nucleophilic attack at C12. The signature
overall double-stereochemical inversion at this position
implicates the intermediacy of the oxonium ion. It is interesting
to speculate whether these diﬀerent oxonium ion formation−
fragmentation metabolites are formed with inherent selectivity
because they arise from diﬀerent starting diastereomeric forms
or whether the compounds are simply representative isolates of
all possible fragmentations of such oxonium ions. Herein, in an
experimental exploration of the above, we report on an
asymmetric strategy for the synthesis of two bicyclic 12-
membered ring ethers as C4-epimeric nitrile epimers 9 and 10
(Figure 1, D) as putative synthetic precursors of obtusallene II
and obtusallene IV. We demonstrate that the latter can serve as
an advanced precursor for the synthesis of 12-epoxyobtusallene
IV (7), thereby achieving the ﬁrst total synthesis of a C15-ACG
with a 12-membered ether ring from Laurencia species.
Moreover, we demonstrate face-selective oxidations of nitrile
epimers 9 and 10, thereby enabling remarkably selective and
high-yielding diastereodivergent transannular oxonium ion
formation−fragmentations for the total synthesis of obtusallene
X (8) via 12S-oxonium ions of the type B′ and
marilzabicycloallenes C (5) and D (6) via 12S,13S-onium
ions A (X = OH, Cl, respectively) and thus 12R-oxonium ions
of type B.
■ RESULTS AND DISCUSSION
Single enantiomer nitriles 9 and 10 were envisaged to be
formed from epimeric acyclic dienes 11 and 12 via ring-closing
metathesis, which in turn were expected to be accessible from
bromochlorotetrahydrofuran 13 as a common intermediate
(Scheme 1). We have previously reported the synthesis of
(±)-1318 which we have now adapted to an asymmetric
method utilizing Yamamoto’s catalytic enantioselective homo-
allylic epoxidation method.20 Accordingly, known enediyne 14,
prepared as previously described,18 underwent transfer hydro-
genation to (Z,Z)-doubly skipped triene 15 using a zinc−
copper couple in a mixed solvent system of 2-propanol and
water, avoiding over-reduction of the terminal alkene under
these conditions (Scheme 2). Directed, catalytic asymmetric
epoxidation of homoallylic alcohol 15 using Yamamoto’s
conditions and ligand 17 gave the desired epoxide 16. The er
of epoxide 16 was determined by conversion to its O-trityl
derivative 18 followed by chiral HPLC analysis revealing an er
of 91:9 (see the Supporting Information) and where the
absolute conﬁguration of the major enantiomer was assigned by
anology to Yamamoto’s work. The subsequent steps of
regioselective epoxide ring opening (giving 19), silyl protection
of the primary alcohol (giving 20), diastereoselective
bromoetheriﬁcation (giving 21), and deprotection to bromo-
chlorotetrahydrofuran 13 employed the previously reported
conditions for the preparation of (±)-1318 with minor
modiﬁcations. With alcohol 13 in hand, it was oxidized to
the corresponding aldehyde followed by immediate acetaliza-
tion with the single enantiomer (S)-but-3-yn-2-ol under acidic
catalysis to give acetal 22. In this reaction, the addition of
Figure 1. Structures and putative biogeneses of obtusallene and marilzabicycloallene C15-ACGs.
Scheme 1. Retrosynthesis of Nitriles 9 and 10
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sodium borohydride as part of the workup procedure allowed
recycling of unreacted material by recovery of alcohol 13.
Subsequent cyanation of the acetal with trimethylsilyl cyanide
as catalyzed by boron triﬂuoride etherate21 gave the separable
cyanoethers 23 and 24 in excellent yield with essentially perfect
stereodivergence (1:1 ratio), presumably via the intermediacy
of a planar oxonium ion. Hydrogenation of each individual
epimer gave acyclic dienes 11 and 12 in high yield. With these
acyclic dienes in hand, we explored the proposed ring-closing
metatheses to form E-macrocyclic epimers 9 and 10. After
much experimentation, and much to our delight, ring-closing
metathesis using Hoveyda−Grubbs ruthenium benzylidene
precatalyst22a for diene 11 and second-generation Hoveyda−
Grubbs precatalyst22b for diene 12 in rigorously dry toluene at
high dilution provided each of the desired E-macrocyclic nitrile
epimers 9 and 10, respectively, as the major product in good
yields. In this chemistry, the incorporation of enantiomerically
pure (S)-but-3-yn-2-ol into enantiomerically enriched (91:9)
aldehyde 13 resulted in the formation of a minor
diastereoisomer. The minor diastereoisomer was carried
through in each subsequent step to acyclic dienes 11 and 12
as an inseparable entity. After RCM, both macrocycles 9 and 10
were puriﬁed as single diastereoisomers, meaning that these
compounds are enantiomerically pure.
Single crystal X-ray crystallography of each epimer 9 and 10
unambiguously established their structures conﬁrming all
relative and absolute stereochemistries (Figure 2). These X-
ray crystal structures were compared with the previously
obtained X-ray structures of obtusallenes II (1)11 and IV (2),13
respectively. This comparison established three important
details. First, the epimeric macrocycles of 9 and 10 map
perfectly onto the macrocyclic solid-state structures of 1 and 2,
respectively (see the Supporting Information), showing that
these compounds are excellent model compounds of the
natural products. Second, in the solid state, each compound
exposes its Re face of the C12−C13 alkene where the Si face is
blocked by the tetrahydrofuran. Thus, it is to be expected that
12R,13R-conﬁgured 12-epoxyobtusallene IV (7) could arise
biogenetically by epoxidation of the exposed Re face of
obtusallene IV (2). However, the proposed obtusallene-to-
Scheme 2. Asymmetric Synthesis of Nitriles 9 and 10
Figure 2. Crystal structure of 9 (50% probability ellipsoids) (left). Structure of one of the two independent molecules present in the crystal of 10
(50% probability ellipsoids) (right).
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marilzabicycloallene interconversions require oxidation of the Si
face of the oleﬁns via 12S,13S-conﬁgured onium ions A (cf.
Figure 1B). This apparent incongruity can be rationalized by
noting that in solution obtusallenes II and IV have been shown
to exist as interconverting alkene conformers, thereby exposing
both Re and Si faces of the alkene.12,14 This conformational
interconversion manifests itself by broadened NMR signals for
these compounds at room temperature. Epimeric nitriles 9 and
10 also display broadened NMR signals (see the Supporting
Information) indicating that they behave in the same manner
and are expected to expose both Re and Si faces of their alkenes
in solution. As a third detail, we note that the X-ray crystal
structures reveal that the two epimeric nitriles 9 and 10 have
dif ferent local conformations around the C5−C4−O−C14
torsion angle such that the nitrile group bisects the hydrogen
atoms on C5 in each case. Herein must lie the origin of their
epimeric face-selective oxidative behavior (vide infra).
With epimeric nitriles 9 and 10 in hand, we planned to
reduce each one to the corresponding aldehyde and then use
well-established procedures23 to install bromoallene function-
alities leading to obtusallene II (1) and IV (2), respectively.
Remarkably, there are no examples in the literature of the
partial reduction of (allyloxy)acetonitriles, and DIBAL-H
reduction of either nitrile proved to be unexpectedly trouble-
some and only minor quantities (ca. 10%) of the expected
aldehydes could be obtained.24 The use of model substrates25
established that the allylic ether functional group in each is
problematic, where the corresponding saturated or epoxidized
model was converted to its aldehyde using DIBAL-H without
incident. Accordingly, the attempted direct reduction of nitrile
allylic ethers 9 and 10 with DIBAL-H was abandoned.
Epoxidation of nitrile 10 was then explored with a view
toward accessing 12R,13R-conﬁgured 12-epoxyobtusallene IV
(7) as a known natural product by subsequent selective nitrile
reduction and installation of the requisite bromoallene. In the
event, epoxidation of unsaturated nitrile 10 provided epoxides
25 and 26 in quantitative isolated yield in a 1:3 ratio, where the
major product is the 12R,13R-conﬁgured epoxide (Scheme 3).
As per the discussion above, this demonstrates that both Re and
Si faces of the alkene in epimer 10 are accessible in solution,
and for this epimer, the Re face is evidently subject to faster
oxidation. Pleasingly, subsequent DIBAL-H reduction of epoxy
nitrile 26 now proceeded smoothly, corroborating our ﬁndings
from the earlier model studies. Bromoallene installation23 was
subsequently achieved via magnesium acetylide addition to the
newly formed aldehyde to provide separable epimeric alcohols.
The required alcohol 27 was converted to trisylate 28, and
copper-mediated SN2′ bromide incorporation provided 12-
epoxyobtusallene IV (7).15,26 To test the proposed relationship
of 12-epoxyobtusallene IV (7) to obtusallene X (8) (cf. Figure
1C) it was treated with HBr in dichloromethane solution.
Much to our delight, obtusallene X (8)15 was produced in
essentially quantitative yield.27 This experiment thereby
supports its probable biogenesis via transannular formation of
12S-oxonium ion B′ and reinversion of conﬁguration by attack
of the nucleophile at C12. We recognized also that
deoxygenation of 12-epoxyobtusallene IV (7) would provide
synthetic access to obtusallene IV (2). However, despite
successful deoxygenation in model studies with a representative
chlorobromoepoxide, attempted deoxygenation of 12-epoxyob-
tusallene IV (7) under the same conditions was unsuccessful.28
Finally, the formation of 12S,13S-epoxide 25 in the epoxidation
of alkene 10 also has biogenetic signiﬁcance. Marilzabicycloal-
lene B (4) is proposed to arise from the 12S,13S-epoxide of
obtusallene IV via oxonium ion B (cf. Figure 1B, X = OH, R =
4R-(S)-CHCCHBr).16 This is the ﬁrst experimental
evidence that such an 12S,13S-epoxide can be accessed in the
obtusallene IV skeleta.29 However, we elected to explore the
obtusallene-to-marilzabicycloallene rearrangements in the
obtusallene II manifold instead (vide infra).
In contrast to the behavior of nitrile 10, epoxidation of
epimeric nitrile 9 under the same conditions gave 12S,13S-
epoxide 29 as eﬀectively the only component in essentially
quantitative yield (Scheme 4). Evidently, for this epimer, Si face
oxidation is now favored. We suggest that for this epimer
12S,13S-epoxide formation results in a compound with minimal
transannular strain. With a 12S,13S-epoxide of the obtusallene
II framework in hand, we elected to explore the proposed
obtusallene-to-marilzabicycloallene rearrangements (cf. Figure
1B). Much to our delight, on treatment with catalytic acid in
methanolic solvent, 12S,13S-epoxide 29 was found to rearrange
smoothly to bicyclo[5.5.1]tridecane nitrile 30 in essentially
quantitative yield, thus validating the proposed transannular
oxonium ion formation−fragmentation as mediated by a
protonated epoxide where 12R-oxonium ion B (cf. Figure 1B,
X = OH, R = 4S-CN) undergoes preferential nucleophilic
attack (NuH = MeOH) at C9. Alternatively, DIBAL-H
reduction of epoxy nitrile 29 followed by magnesium acetylide
addition gave alcohol 31 along with its inseparable minor
epimer, and bromoallene installation to give epoxide 32 was
subsequently completed using an adaption of the established
methods.23 To our further delight, fully elaborated bromoallene
epoxide 32 was also found to rearrange cleanly with catalytic
acid in methanolic solvent to provide marilzabicycloallene C
(5)16,26 in essentially quantitative yield. Not only does this
demonstrate the further validity of the proposed obtusallene-to-
marilzabicycloallene biogenetic pathway (cf. Figure 1B, X =
OH, R = 4S-(R)-CHCCHBr), it also implicates epoxide
Scheme 3. Synthesis of 12-Epoxyobtusallene IV and
Obtusallene X
The Journal of Organic Chemistry Featured Article
DOI: 10.1021/acs.joc.6b02008
J. Org. Chem. 2016, 81, 9539−9552
9542
32, which we name 12-epoxyobtusallene II, as a yet to be
discovered natural product from Laurencia species.30
The experimentally demonstrated diastereodivergent selec-
tivity observed for the position of nucleophilic attack in the
above studies is intriguing and requires comment. There is
obviously the initial question of epimeric face selectivity in the
epoxidation of alkenes 9 and 10, but once in place the
conﬁguration of any 12S,13S or 12R,13R epoxide necessarily
control the conﬁgurations of the resulting respective oxonium
ion 12R-B versus 12S-B′ by stereospeciﬁc transannular epoxide
ring opening.31 For each trisubstituted oxonium ion32 there are
actually three possible positions of nucleophilic attack, C6,
33 C9,
and C12 ,where the nucleophile must approach with the normal
backside stereoelectronic constraints of SN2-type substitution.
For both oxonium ions B and B′ inspection of the structures
reveals that each one of these carbons is classiﬁed as secondary.
Each one is also ﬂanked by one methylene unit (C5, C8, and
C11, respectively) and one secondary carbon each bearing a
heteroatom (C7-Cl, C10-Br, and C13-OH). We chose to focus
on oxonium ion 12R-B for a more detailed computational
analysis of the possible factors controlling the regiochemical
outcome.
Three diﬀerent types of model were constructed, initially for
X = OH, R = 4S-Me. The ﬁrst involved inspecting the wave
function of the reactant oxonium cation 12R-B itself. The
conformational space of the larger 8-ring is complex; a partial
exploration of this space showed the conformation of the
reasonably related oxonium cation34 for which a crystal
structure is known, which coincided with the lowest energy
conformation computed for 12R-B at the ωB97X-D/Def2-
TZVPPD level using a self-consistent reaction ﬁeld solvent
model (cpcm, solvent = methanol). Both this conformation and
computational method were used for the subsequent studies.35
We also included in the study a reactant-based model as both a
positively charged oxonium cation and with a model non-
interacting counterion BF4
− as a neutral ion pair.
NBO (natural bond orbital) localization of the wave function
for both models allowed the relative energies of the three C−O
σ* accepting orbitals to be compared (Figure 3). For the ion
pair, the NBO energies increased in the order C9 0.230 > C12
0.241 > C6 0.245 hartree, indicating the optimal position for
nucleophilic attack is predicted by this approach to be at the
best electron-accepting position, C9. The corresponding
energies for 12R-B as just a cation were C9 0.198 > C6 0.207
> C12 0.225 hartree, again predicting nucleophilic attack at the
C9−O bond and coinciding with the actual outcome.
The next evolution of our reaction model was to compute
the properties of transition states for reactions of a variety of
nucleophiles interacting directly with the oxonium cation 12R-
B (R = 4S-Me). With X = OH, we used clusters of both one
MeOH and two MeOH, the latter interacting via hydrogen
bonding and also anionic MeO− and Br− nucleophiles as ion
pairs (Table 1).36 In every case, the transition state of lowest
free energy corresponded to attack at C12, promoted by the
directing inﬂuence of the adjacent hydroxyl group at C13. When
X = Cl, this eﬀect was attenuated, and now the lowest free
energy transition state emerged at C6. Finally, we added a
noninteracting counterion BF4
− to the transition-state model,
locating the counterion in the same pocket for all three
transition states. Now, C9 and C6 emerged as both lower than
C12. The promotion of the C9 position was because the dipole
moment of this transition state was signiﬁcantly lower than the
Scheme 4. Synthesis of Marilzabicycloallene C
Figure 3. Representation of the NBOs computed for the C−O σ* accepting orbitals for the 12R-B ion pair using BF4− as the counterion for (a) C6,
(b) C9, and (c) C12. Interactive versions of these ﬁgures are available.
36
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other two isomers, resulting in stabilization from lower charge
separation (Figure 4).
This was also true for the other two ion-pair models using
anionic MeO− and Br− as nucleophiles, where the transition
state with the lowest dipole moment/charge separation was
also the lowest in free energy.
Two principle conclusions can be drawn from these results.
First, this model is an unusually complex one due to factors
such as the conformational ﬂexibility of the larger 8-membered
ring, the hydrogen-bonding interactions possible with the
incoming nucleophile, and the possibility of positional diversity
of the counterion associated with the oxonium cation. A
complete stochastic nondynamic exploration of each of these
variables is not possible for a system of this size, and we cannot
claim to have reduced each of these to the global lowest energy
structures. Nevertheless, one interesting conclusion that can be
drawn is that the reaction of an ion pair with a nucleophile may
be strongly inﬂuenced by the charge-separation/dipole moment
of the resulting highly ionic transition states. This is in addition
to the more obvious structural features such as steric
interactions or local hydrogen bonding. Thus, the regiochem-
ical outcome of such reactions may well be determined by a
complex blend of these various eﬀects, with perhaps no one
eﬀect dominating. Certainly, the simpler analysis based purely
on just the properties of the reactant oxonium cation should be
considered as far too simplistic, even though in this speciﬁc case
it predicts the “correct” outcome, for probably the wrong
reasons.
Having demonstrated that a group VI onium ion from a
preformed epoxide can drive these transannular rearrange-
ments, we undertook to attempt the use of a group VII onium
ion generated directly f rom oleﬁn 9 to do so. With
marilzabicycloallene D (6) as the intended target, we were
delighted to ﬁnd that the combination of catalytic quantities of
TMG37 and stoichiometric quantities of NCS and TMSCl38 in
dichloromethane eﬀected the transformation of oleﬁn 9 into
trichlorobromide bicyclo[5.5.1]tridecane 33 in excellent
isolated yield (Scheme 5). Evidently, the Si face of epimer 9
is again subject to kinetically controlled oxidation, now as the
12S,13S-chloronium ion A (cf. Figure 1B, X = Cl, R = 4S-CN),
followed by stereospeciﬁc transannular oxonium ion 12R-B
formation by chloronium ion ring-opening. As per the
previously observed fragmentations of 12R-B oxonium ions
(vide supra), the same remarkable selectivity for the C9-
position is observed, presumably for the same reasons, but now
with chloride anion functioning as the nucleophile. Subsequent
DIBAL-H reduction of the nitrile, which proceeded without
complication, and installation of the bromoallene23 via alcohol
34 provided marilzabicycloallene D (6).16,26
Table 1. Computed Reaction Free Energy Barriers (kcal/mol−1) for Obtusallene-Derived Oxonium and Chloronium Cations
and Ion Pairsa
nucleophile @C6 @C9 @C12
Nucleophilic Attack on Oxonium Cation 12R-B
MeOH 21.9,c bfd2b 23.2, bjqc 21.3, bfcr
32.1,d bfcs 0.0, bj96;e 2.0, bj99f
2MeOH 26.4, bjnj 18.8, bjmw
0.0, bnhze
Br− 18.0 (16.1),g bfcj 17.5 (14.5),g bfck 14.7 (11.1),g bfcm
0.0, bnrde
MeO− 21.1 (15.5),g bfcn 18.6 (15.5),g bfcp 10.9 (11.0),g bfcq
0.0, bnh6e
Nucleophilic Attack on Chloronium Cation
MeOH 16.8, bj8z 17.9, bj95 18.4, bj82
0.0, bn5ne
Nucleophilic Attack on Oxonium Cation/BF4
− Model Ion Pair
MeOH 20.0 (24.5),g bksg 20.3 (15.0),g bj97 20.5 (26.5),g bj98
0.0, bnhqe
aSee ref 36 for an interactive FAIR data version of this table. bDigital object identiﬁer (DOI) for managed research data, resolved as, e.g. http://doi.
org/bfd2. See also ref 35. cActivation free energies as ΔG⧧298 for a ωB97XD/Def2-TZVPPD/SCRF = methanol model.
dAlternative conformation
for 8-membered ring. eReactant. fProduct. gDipole moment, D.
Figure 4. Computed dipole moment vectors for the computed transition states for nucleophilic attack by methanol at the (a) C6, (b) C9, and (c) C12
positions of 12R-B.
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Thus, we have accomplished the total synthesis of 12-
epoxyobtusallene IV (7) and 12-epoxyobtusallene II (32) (as a
yet to be discovered natural product from Laurencia species) as
the ﬁrst C15-ACGs with 12-membered ether rings. To the best
of our knowledge, these also constitute the ﬁrst total syntheses
of any tricyclic ethers of this class of C15-ACGs. We also report
the total synthesis of obtusallene X (8), marilzabicycloallene C
(5), and marilzabicyclocallene D (6) via consideration,
proposition, and exempliﬁcation of their biogeneses via
oxonium ion formation−fragmentation reactions. These studies
show that these metabolites are not simply representative
isolates of all possible formation−fragmentations of such
oxonium ions but rather are produced by inherently selective
pathways. A density functional mechanistic exploration of one
of these pathways involving ring opening of an intermediate
ion-pair complex suggests that a major factor in the selectivity
may be the dipole moment magnitude at the transition state.
■ EXPERIMENTAL SECTION
General Information. Quinoline was dried over Na2SO4 and
distilled from and stored over Zn dust. Triethylamine was dried over
CaSO4 prior to distillation under nitrogen and was subsequently
stored over 4 Å molecular sieves. TBCO was prepared according to
the method of Matveeva.39 Asymmetric epoxidation ligand 17 was
prepared according to the method of Yamamoto.20b All other reagents
were obtained from commercial sources and used as received. All
reactions were performed in anhydrous solvents unless used in
combination with H2O. CH2Cl2, THF, and Et2O were dried by passing
through a column of alumina beads. Toluene was distilled from
sodium and benzophenone immediately before use. MeOH, EtOH,
MeCN, and glacial AcOH were used as received. Extraction solvents
and chromatography eluents were used as received. MeOH and
CH2Cl2 were HiPerSolv grade, EtOH was AnalaR grade, and n-hexane,
Et2O, EtOAc, and petroleum spirit 40−60 °C were GPR grade.
Benzene was purchased and used as received. Reactions were carried
out in oven-dried glassware under an inert atmosphere of nitrogen
unless otherwise stated. Air- and moisture-sensitive reagents were
transferred by syringe or cannula. Molecular sieves (4 Å) were dried by
repeatedly heating under vacuum and ﬂushing with nitrogen. Reaction
temperatures other than room temperature were recorded as
aluminum heating block or bath temperatures. Temperatures below
room temperature were achieved by an ice/NaCl bath or acetone/dry
ice bath. Brine refers to a saturated aqueous solution of NaCl. Column
chromatography was performed on silica gel, particle size 33−70 μm
or 40−63 μm. Analytical TLC was performed on Kieselgel 60 F254
precoated aluminum-backed plates which were visualized by ultraviolet
light (254 and 350 nm) and/or chemical staining using potassium
permanganate or an acidiﬁed solution of vanillin. Fourier transform IR
spectra were recorded as neat samples using an ATR-IR spectrometer.
1H NMR spectra were recorded at 400 or 500 MHz. 13C{1H} NMR
spectra were recorded at 101 or 126 MHz. Chemical shifts (δ) are
quoted in parts per million (ppm) and are referenced to the residual
solvent peak. Coupling constants (J) are quoted in hertz (Hz). All
NMR spectra were acquired at room temperature unless otherwise
stated. Low-resolution MS were performed using ESI, EI, or CI
methods and ToF or magnetic sector analysis. Chiral analytical HPLC
was performed on a 25 cm × 4.6 mm ChiralPak AD or ODH column.
All solvents for HPLC were HiPerSolv grade and used as received.
(3Z,6Z)-Deca-3,6,9-trien-1-ol (15). Freshly prepared zinc−copper
couple (1.32 kg) was added to a solution of dec-9-ene-3,6-diyn-1-ol
(14) (33 g) in water (1.0 L) and 2-propanol (65 mL) at room
temperature. After being stirred for 24 h, the mixture was diluted with
additional water and stirred for a further 12 h. The suspension was
ﬁltered through a sintered funnel and washed with diethyl ether. The
layers were separated and the organics dried over Na2SO4 and
subsequently ﬁltered. The solvent was removed in vacuo and the crude
mixture subjected to column chromatography (petroleum spirit/ethyl
acetate 9:1−4:1) to provide product 15 (21 g, 62% over three steps) as
a colorless oil: Rf 0.40 (petroleum spirit/ethyl acetate 2:1). All other
data as previously reported.18
(3R,4S,6Z)-3,4-Epoxydodeca-6,9-dien-1-ol (16). Vanadyl(V) iso-
propoxide (0.33 mL, 1.38 mmol, 0.01 equiv) was added to a solution
of bishydroxamic acid 17 (2.89 g, 2.75 mmol, 0.02 equiv) in toluene
(140 mL) at room temperature and stirred for 24 h. Cumene
hydroperoxide (30 mL, 206 mmol, 1.5 equiv) was added followed by a
solution of (3Z,6Z)-deca-3,6,9-trien-1-ol (15) (20.9 g, 138 mmol, 1.0
equiv) in toluene (140 mL). The reaction mixture was stirred for 12
days at room temperature after which it was quenched with Na2SO3
solution (1 L). The aqueous was extracted with ethyl acetate (3 × 600
mL), the combined organics were dried over Na2SO4 and ﬁltered, and
the solvent was removed in vacuo. The crude mixture was subjected to
column chromatography (100% petroleum spirit, to petroleum spirit/
ethyl acetate 1:1) to provide epoxide 16 (18.2 g, 79%) as a pale red oil:
Rf 0.25 (petroleum spirit/ethyl acetate 1:1); [α]
25
D +12.7 (c 0.30,
CH2Cl2). All other data as previously reported.
18
(3R,4S,6Z)-3,4-Epoxydodeca-6,9-dien-1-yl Trityl Ether (18). Trie-
thylamine (0.06 mL, 0.45 mmol, 1.5 equiv) and trityl chloride (125
mg, 0.45 mmol, 1.5 equiv) were added to a solution of (3R,4S,6Z)-3,4-
epoxydodeca-6,9-dien-1-ol (16) (51 mg, 0.3 mmol, 1.0 equiv) in
dichloromethane (10 mL) at room temperature and stirred for 18 h at
room temperature. The mixture was washed with aqueous ammonium
chloride (10 mL) and brine (10 mL), the organics were then dried
over Na2SO4 and ﬁltered, and the solvent was removed in vacuo. The
crude mixture was puriﬁed by column chromatography (petroleum
spirit/ethyl acetate 98:2, to 95:5) to provide the title compound 18
(20 mg, 16%) as a colorless oil: Rf 0.37 (petroleum spirit/ethyl acetate,
10:1); [α]25D +6.1 (c 0.45, CH2Cl2); IR (neat) 3056, 3019, 2975,
2925, 2873, 1637, 1490, 1448, 1218, 1072, 1031, 900, 761 cm−1; 1H
NMR (400 MHz, CDCl3) δ 7.46−7.46 (m, 6H), 7.34−7.31 (m, 6H),
7.28−7.24 (m, 3H), 5.83 (ddt, J = 16.3, 10.0, 6.1 Hz, 1H), 5.60−5.49
(m, 2H), 5.09−5.00 (m, 2H), 3.30 (t, J = 6.4 Hz, 2H), 3.17−3.13 (m,
1H), 3.01−2.96 (m, 1H), 2.82 (br t, J = 6.3 Hz, 2H), 2.41−2.34 (m,
1H), 2.28−2.20 (m, 1H), 1.94−1.81 (m, 2H); 13C{1H} NMR (100
MHz, CDCl3) δ 144.1, 136.4, 129.4, 128.7, 127.8, 127.0, 125.3, 115.0,
86.7, 61.1, 56.3, 54.9, 31.7, 28.7, 26.3; MS (ESI+) m/z 433 (M + Na)+;
HRMS (ESI+, TOF) m/z [M + Na]+ calcd for C29H30O2Na 433.2144,
found 433.2152; HPLC (OD-H), n-hexane/EtOH = 99:1, injection
volume = 10 μL, ﬂow rate = 0.5 mL/min, column oven temperature =
20 °C, tR = 15.9 min (major) (3R,4S), tR = 14.9 min (minor) (3S,4R);
e.r. 91:9.
(3R,4R,6Z)-4-Chlorodeca-6,9-diene-1,3-diol (19). According to the
reported procedure for the racemate,18 diethylamine hydrochloride
(20.8 g, 189 mmol, 5.3 equiv) and titanium(IV) isopropoxide (15.8
mL, 54 mmol, 1.5 equiv) were added to a solution of (3R,4S,6Z)-3,4-
epoxydeca-6,9-dien-1-ol (16) (6.0 g, 36 mmol, 1.0 equiv) in
dichloromethane (720 mL) at room temperature. After the solution
Scheme 5. Synthesis of Marilzabicycloallene D
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was stirred for 5 days, saturated tartaric acid (800 mL) was added and
the precipitate was ﬁltered oﬀ using a sinter and washed thoroughly
with dichloromethane (300 mL). The aqueous was extracted with
dichloromethane (3 × 200 mL), and the combined organics were
washed with sodium bicarbonate (400 mL) and brine (400 mL). The
organics were dried over Na2SO4 and ﬁltered, and the solvent was
removed in vacuo. The crude mixture was subjected to column
chromatography (petroleum spirit/ethyl acetate 2:1) to provide the
title compound 19 an inseparable mixture of the two chlorohydrin
regioisomers (5.2 g, 71%) in a 5:1 ratio as a colorless oil: Rf 0.21
(petroleum spirit/ethyl acetate 1:1); [α]21D +9.4 (c 0.55, CH2Cl2). All
other data as previously reported.18
(3R,4R,6Z)-1-(tert-Butyldiphenylsilanyloxy)-4-chlorodeca-6,9-
dien-3-ol (20). By a modiﬁcation of the reported procedure for the
racemate,18 imidazole (4.14 g, 61 mmol, 2.4 equiv) and TBDPS-Cl
(6.58 mL, 25 mmol, 1.0 equiv) were added sequentially to a solution
of (3R,4R,6Z)-4-chlorodeca-6,9-diene-1,3-diol (19) (5.20 g, 25 mmol,
1.0 equiv) in THF (180 mL) at 0 °C. The reaction mixture was
allowed to warm to room temperature and stirred for 18 h. The
mixture was diluted with ethyl acetate (600 mL) and washed with
water (500 mL) and brine (500 mL). The organics were dried over
Na2SO4 and ﬁltered, and the solvent was removed in vacuo. The crude
mixture was subjected to column chromatography (petroleum spirit/
ethyl acetate 20:1) to provide product 20 (8.29 g, 74%) as a colorless
oil: Rf 0.46 (petroleum spirit/ethyl acetate 9:1); [α]
23
D +6.1 (c 0.95,
CH2Cl2). All other data as previously reported.
18
(2R,3R,5S)-5-((S)-1-Bromobut-3-enyl)-2-(2-(tert-butyldiphenyl-
silyloxy)ethyl)-3-chlorotetrahydrofuran (21). By a modiﬁcation of the
reported procedure for the racemate,18 TBCO (1.11 g, 2.7 mmol, 1.2
equiv) was added to a solution of (3R,4R,6Z)-1-(tert-butyldiphenylsi-
lanyloxy)-4-chlorodeca-6,9-dien-3-ol (20) (1.00 g, 2.3 mmol, 1.0
equiv) in dichloromethane (60 mL) at −78 °C. The reaction mixture
was allowed to warm slowly to room temperature and stirred for a
period of 18 h. The mixture was subsequently diluted with ethyl
acetate (100 mL) and washed with sodium bicarbonate (50 mL) and
brine (50 mL). The organics were dried over Na2SO4 and ﬁltered, and
the solvent was removed in vacuo. The crude mixture was puriﬁed by
column chromatography (petroleum spirit/ethyl acetate 25:1) to
provide product 21 (1.06 g, 90%) as a pale yellow-brown oil: Rf 0.51
(petroleum spirit/ethyl acetate 9:1); [α]23D −1.5 (c 0.52, CH2Cl2). All
other data as previously reported.18
2-[(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetrahydro-
furan-2-yl]ethanol (13). By a modiﬁcation of the reported procedure
for the racemate,18 TBAF (1.0 M in THF, 25.6 mL, 26.1 mmol, 3.0
equiv) was added dropwise to a solution of (2R,3R,5S)-5-((S)-1-
bromobut-3-enyl)-2-(2-(tert-butyldiphenylsilyloxy)ethyl)-3-chlorote-
trahydrofuran (21) (4.52 g, 8.7 mmol, 1.0 equiv) and AcOH (2.4 mL,
43.5 mmol, 5.0 equiv) in THF (270 mL) at 0 °C. The reaction mixture
was stirred at 0 °C for 1 h and at room temperature for 3 h. A further
portion of AcOH (2.4 mL, 43.5 mmol, 5.0 equiv) was added, and
additional TBAF (1.0 M in THF, 25.6 mL, 26.1 mmol, 3.0 equiv) was
added after cooling to 0 °C. The reaction mixture was allowed to
slowly warm to room temperature over a period of 18 h. It was diluted
with ethyl acetate (500 mL) and washed with sodium bicarbonate
(250 mL). The aqueous portion was extracted with ethyl acetate (3 ×
200 mL), and the organics were subsequently combined and washed
with brine (400 mL) and dried over Na2SO4. The solvent was
removed in vacuo and the crude mixture puriﬁed by column
chromatography (petroleum spirit/ethyl acetate 2:1) to provide
product 13 (1.97 g, 80%) as a pale yellow oil: Rf 0.38 (petroleum
spirit/ethyl acetate 1:1); [α]24D +4.3 (c 1.01, CH2Cl2). All other data
as previously reported.18
(2R,3R,5S)-2-[2,2-Bis[(2S)-but-3-yn-2-yloxy]ethyl]-5-[(1S)-1-bro-
mobut-3-en-1-yl]-3-chlorooxolane (22). To a stirred solution of
alcohol 13 (495 mg, 1.75 mmol) in CH2Cl2 (7 mL) at 0 °C was added
Dess−Martin periodinane (1.48 g, 75% active, 2.62 mmol, 1.5 equiv).
The white suspension was allowed to warm to room temperature and
stirred for 30 min until TLC (n-hexane/EtOAc 2:1) showed
completion of the reaction. The mixture was passed through a silica
plug, eluting with n-hexane/EtOAc 2:1, and the solvent was removed
in vacuo to give a light yellow oil (498 mg). This material was carried
through to the next step without further puriﬁcation.
To a stirred solution of the crude aldehyde (498 mg) in (2S)-but-3-
yn-2-ol (1.75 mL, 22.3 mmol) at room temperature was added CSA
(51.9 mg, 0.223 mmol, 0.13 equiv), and the yellow solution was heated
to 40 °C. After 1 h, NaBH4 (704 mg, 1.74 mmol) was added, followed
by THF (3 mL). After a further 30 min at 40 °C, water (5 mL) was
added, the mixture was extracted with CH2Cl2 (3 × 5 mL), dried over
Na2SO4, ﬁltered, and the solvent was removed in vacuo to give a
colorless oil (699 mg). Column chromatography (n-hexane/EtOAc
4:1) gave the title compound 22 (450 mg, 1.11 mmol, 64% over two
steps, 95% brsm) as a colorless oil: Rf 0.61 (n-hexane/EtOAc 2:1); IR
(neat) 3296, 2924, 1736, 1091, 1040 cm−1; 1H NMR (400 MHz;
CDCl3) δ 5.87 (ddt, J = 17.0, 10.2, 6.9 Hz, 1H), 5.21−5.13 (m, 2H),
5.09 (t, J = 5.8 Hz, 1H), 4.63 (qd, J = 6.5, 1.8 Hz, 1H), 4.57 (dd, J =
4.7, 2.9 Hz, 1H), 4.51−4.40 (m, 2H), 4.29 (td, J = 6.8, 2.8 Hz, 1H),
4.01 (ddd, J = 8.6, 5.4, 3.1 Hz, 1H), 2.72 (ddd, J = 9.7, 7.7, 6.4 Hz,
2H), 2.54 (ddd, J = 14.3, 9.7, 4.8 Hz, 1H), 2.46 (d, J = 2.0 Hz, 1H),
2.42 (d, J = 2.0 Hz, 1H), 2.36 (dd, J = 13.6, 5.9 Hz, 1H), 2.18 (ddd, J =
13.6, 7.3, 6.1 Hz, 1H), 2.02 (dt, J = 13.8, 6.1 Hz, 1H), 1.46 (d, J = 5.7
Hz, 3H), 1.45 (d, J = 5.5 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3)
δ 134.8, 118.1, 98.1, 84.2, 84.0, 79.3, 78.6, 73.0, 72.9, 62.8, 62.3, 61.7,
58.0, 41.1, 40.0, 36.7, 22.6, 22.0; MS (ES+, TOF) 425 [M + Na]+;
HRMS (ES+, TOF) m/z [M + Na]+ calcd for C18H24O3Na
35Cl79Br
425.0495, found 425.0509. Starting alcohol 13 (180 mg, 0.635 mmol,
36%) ws also obtained as a colorless oil.
(2S)-3-[(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorooxo-
lane-2-yl]-2-[(2S)-but-3-yn-2-yloxy]propanenitrile ((S)-23) and (2R)-
3-[(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorooxolane-2-yl]-
2-[(2S)-but-3-yn-2-yloxy]propanenitrile ((R)-24). According to a
modiﬁed procedure,21 to a stirred solution of acetal 22 (280 mg,
0.694 mmol) in CH2Cl2 (1 mL) at room temperature were added
trimethylsilyl cyanide (217 μL, 1.73 mmol, 2.5 equiv) and BF3.OEt2
(12 μL, 0.0972 mmol, 0.14 equiv). The orange solution was stirred for
2 h until TLC (n-hexane/EtOAc 9:1) showed completion of the
reaction. The reaction was quenched with water (1 mL) and stirred for
a further 15 min. The mixture was extracted with CH2Cl2 (3 × 3 mL),
dried over Na2SO4, and ﬁltered and the solvent removed in vacuo to
give an orange oil (350 mg). Column chromatography (n-hexane/
EtOAc 9:1) gave nitrile (S)-23 (130 mg, 0.360 mmol, 52%) as a
colorless oil: Rf 0.29 (n-hexane/EtOAc 9:1); [α]
28
D −13.3 (c 0.42,
CH2Cl2); IR (neat) 3296, 2992, 2945, 2116, 1645, 1439, 1375, 217,
1095 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.86 (ddt, J = 17.0, 10.2,
6.8 Hz, 1H), 5.22−5.12 (m, 2H), 4.73 (t, J = 7.0 Hz, 1H), 4.58−4.54
(m, 1H), 4.53−4.42 (m, 2H), 4.41 (ddd, J = 8.2, 5.5, 3.0 Hz, 1H), 4.01
(ddd, J = 8.6, 5.8, 3.0 Hz, 1H), 2.73 (ddd, J = 8.1, 6.3, 4.9 Hz, 2H),
2.58 (ddd, J = 14.3, 9.5, 4.9 Hz, 1H), 2.55 (d, J = 2.0 Hz, 1H), 2.44−
2.33 (m, 2H), 2.18 (ddd, J = 13.8, 7.2, 5.6 Hz, 1H), 1.50 (d, J = 6.6 Hz,
3H); 13C{1H} NMR (101 MHz, CDCl3) δ 134.6, 118.2, 117.6, 81.4,
78.8, 78.6, 75.1, 65.0, 64.0, 62.1, 57.4, 40.9, 39.9, 35.4, 21.7; MS (CI+,
NH3) m/z 377, 379, 381 [M + NH4]
+; HRMS (CI+, magnetic sector)
m/z [M + NH4]
+ calcd for C15H23N2O2
35Cl79Br 377.0631, found
377.0635. Nitrile (R)-24 (116 mg, 0.321 mmol, 46%) was also
obtained as a colorless oil: Rf 0.22 (n-hexane/EtOAc 9:1); [α]
28
D +2.1
(c 0.60, CH2Cl2); IR (neat) 3298, 2986, 2935, 1645, 1439, 1312, 1267,
1217, 1094 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.93−5.75 (m, 1H),
5.25−5.08 (m, 2H), 4.59−4.31 (m, 5H), 3.99 (td, J = 7.1, 2.7 Hz, 1H),
2.72 (td, J = 7.1, 1.5 Hz, 2H), 2.63−2.52 (m, 1H) 2.60 (d, J = 2.2 Hz,
1H), 2.38 (dd, J = 14.0, 6.3 Hz, 1H), 2.30−2.09 (m, 2H), 1.49 (d, J =
6.6 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 134.5, 118.7, 118.4,
81.6, 78.4, 77.7, 75.3, 67.3, 63.9, 62.3, 58.3, 41.6, 40.7, 36.7, 21.7; MS
(CI+, NH3) m/z 377, 379, 381 [M + NH4]
+; HRMS (CI+, magnetic
sector) m/z [M + NH4]




2-yl]-2-[(2S)-but-3-en-2-yloxy]propanenitrile (11). To a solution of
nitrile (S)-23 (140 mg, 0.388 mmol) and quinoline (79.8 μL, 0.675
mmol) in benzene (9.70 mL) was added 5% Pd/BaSO4 (41.3 mg,
0.0194 mmol, 5 mol %). The ﬂask was then ﬂushed with hydrogen and
the atmosphere maintained with hydrogen ﬁlled balloons. The black
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suspension was stirred vigorously for 30 min until TLC (n-hexane/
EtOAc 3:1) showed completion of the reaction. The reaction mixture
was passed through a plug of silica, eluting with n-hexane/EtOAc 2:1.
The solvent was removed in vacuo to give a yellow oil (170.2 mg).
Column chromatography (n-hexane/EtOAc 10:1) gave diene 11
(136.5 mg, 0.376 mmol, 97%) as a colorless oil: Rf 0.57 (n-hexane/
EtOAc 3:1); [α]28D −37.5 (c 0.37, CH2Cl2); IR (neat) 2980, 1646,
1433, 1375, 1244, 1088 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.85
(ddt, J = 17.0, 10.1, 6.8 Hz, 1H), 5.61 (ddd, J = 17.5, 10.1, 8.2 Hz,
1H), 5.36−5.26 (m, 2H), 5.18−5.12 (m, 2H), 4.50 (dd, J = 4.8, 3.2
Hz, 1H), 4.43 (ddd, J = 9.5, 6.2, 3.1 Hz, 1H), 4.40−4.33 (m, 2H), 4.14
(app. p, J = 6.4 Hz, 1H), 4.00 (ddd, J = 8.6, 5.7, 3.0 Hz, 1H), 2.72−
2.68 (m, 2H), 2.55 (ddd, J = 14.2, 9.5, 4.9 Hz, 1H), 2.36 (dd, J = 13.9,
6.2 Hz, 1H), 2.27 (dt, J = 14.0, 7.0 Hz, 1H), 2.13 (ddd, J = 13.6, 7.8,
5.0 Hz, 1H), 1.30 (d, J = 6.3 Hz, 3H); 13C{1H} NMR (101 MHz,
CDCl3) δ 137.6, 134.6, 119.2, 118.2, 118.2, 78.9, 78.8, 77.2, 63.4, 62.4,
57.3, 40.9, 39.9, 35.6, 21.3; MS (CI+, NH3) m/z 379, 381, 383 (M +
NH4)
+; HRMS (CI+, magnetic sector) m/z [M + NH4]
+ calcd for
C15H25N2O2
35Cl79Br 379.0788, found 379.0784.
(2R)-3-[(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorooxolan-
2-yl]-2-[(2S)-but-3-en-2-yloxy]propanenitrile (12). To a solution of
nitrile (R)-24 (102 mg, 0.283 mmol) and quinoline (58.1 μL, 0.492
mmol) in benzene (7.00 mL) was added 5% Pd/BaSO4 (30.0 mg,
0.0141 mmol, 5 mol %). The ﬂask was then ﬂushed with hydrogen and
the atmosphere maintained with hydrogen-ﬁlled balloons. The black
suspension was stirred vigorously for 30 min until TLC (n-hexane,
EtOAc 3:1) showed completion of the reaction. The reaction mixture
was passed through a plug of silica, eluting with EtOAc. The solvent
was removed in vacuo to give a yellow oil (162 mg). The oil was
redissolved in EtOAc (∼5 mL) and washed with 1 M HCl (3 × 3 mL).
The solvent was removed in vacuo again to give a yellow oil (111 mg).
Column chromatography (n-hexane/EtOAc 10:1) gave the diene 12
(93.0 mg, 0.256 mmol, 91%) as a colorless oil: Rf 0.35 (n-hexane/
EtOAc 3:1); [α]D
26 +33.3 (c 0.30, CH2Cl2); IR (neat) 2980, 2875,
1643, 1314, 1087 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.93−5.81 (m,
2H), 5.34−5.21 (m, 2H), 5.20−5.13 (m, 2H), 4.49 (dd, J = 4.9, 2.9
Hz, 1H), 4.45−4.34 (m, 3H), 4.14−4.11 (m, 1H), 4.00 (td, J = 7.1, 2.7
Hz, 1H), 2.73 (tt, J = 7.1, 1.3 Hz, 2H), 2.59 (ddd, J = 14.2, 9.5, 4.9 Hz,
1H), 2.39 (dd, J = 13.9, 6.3 Hz, 1H), 2.22 (ddd, J = 14.2, 9.7, 3.2 Hz,
1H), 2.16−2.08 (m, 1H), 1.30 (d, J = 6.3 Hz, 1H), 13C{1H} NMR
(101 MHz, CDCl3) δ 138.7, 134.5, 119.2, 118.3, 117.5, 79.0, 78.4,
77.8, 63.4, 62.4, 58.2, 41.6, 40.7, 36.8, 20.2; MS (CI+, NH3) m/z 379,
381, 383 (M + NH4)
+; HRMS (CI+, magnetic sector) m/z [M +
NH4]
+ calcd for C15H25N2O2
35Cl79Br 379.0788, found 379.0789.
(1R,3S,5S,6E,9S,10S,12R)-9-Bromo-12-chloro-5-methyl-4,13-
dioxabicyclo[8.2.1] tridec-6-ene-3-carbonitri le (9) and
(1R,3S,5S,6Z,9S,10S,12R)-9-Bromo-12-chloro-5-methyl-4,13-
dioxabicyclo[8.2.1] tridec-6-ene-3-carbonitrile (Z-9). Toluene (160
mL) was reﬂuxed in a Dean−Stark apparatus for 1 h. The ﬂask was
removed from the hot plate and allowed to cool before diene 11 (20
mg, 0.055 mmol) and Hoveyda−Grubbs I catalyst22a (10.0 mg, 30 mol
%) were added. The ﬂask was covered with aluminum foil, and the
orange solution was returned to reﬂux for 22 h. The ﬂask was removed
from the hot plate and allowed to cool before di(ethylene glycol) vinyl
ether (6 μL) was added. The solvent was removed in vacuo to give a
brown oil. Column chromatography (toluene) gave the E-macrocycle
9 (10.1 mg, 55%) as white crystals: Rf 0.13 (toluene); mp 136−140
°C; [α]28D +6.2 (c 0.64, CH2Cl2); IR (neat) 2979, 2929, 1443, 1378,
1311, 1268, 1088 cm−1; 1H NMR (400 MHz, 298 K, CDCl3) δ 6.03−
5.87 (m, 1H), 5.68−5.30 (m, 1H), 4.59−4.47 (m, 1H), 4.42 (td, J =
4.9, 2.3 Hz, 1H), 4.03 (dq, J = 8.7, 6.3 Hz, 1H), 2.90−2.64 (m, 2H),
2.46−2.33 (m, 1H), 2.30−2.11 (m, 3H), 1.33 (d, J = 6.3 Hz, 3H); 1H
NMR (400 MHz, 323 K, CDCl3) δ 5.95 (dt, J = 14.5, 7.0 Hz, 1H),
5.55 (dd, J = 15.4, 9.3 Hz, 1H), 4.52 (dd, J = 6.5, 4.9 Hz, 1H), 4.48 (t,
J = 4.6 Hz, 1H), 4.41 (td, J = 4.9, 2.3 Hz, 1H), 4.28−4.12 (m, 2H),
4.02 (dq, J = 8.7, 6.4 Hz, 1H), 2.77 (dd, J = 7.7, 4.2 Hz, 2H), 2.41
(ddd, J = 13.7, 9.5, 6.5 Hz, 1H), 2.29−2.19 (m, 2H), 2.15 (ddd, J =
15.3, 4.9, 2.7 Hz, 1H), 1.33 (d, J = 6.4 Hz, 3H); 13C{1H} NMR (101
MHz, 323 K, CDCl3) δ 133.1, 130.6, 119.3, 81.0, 79.1, 76.4, 66.9, 59.9,
51.4, 41.6, 40.4, 38.3, 21.1; MS (CI+, NH3) m/z 334, 336, 338 [M +
H]+; HRMS (CI+, magnetic sector) m/z [M + H]+ calcd for
C13H18NO2
35Cl79Br 334.0209, found 334.0210. Crystal data for 9:
C13H17BrClNO2, M = 334.64, monoclinic, P21 (no. 4), a =
8.87379(10) Å, b = 4.83007(5) Å, c = 16.63090(14) Å, β =
90.2687(8)°, V = 712.810(12) Å3, Z = 2, Dc = 1.559 g cm
−3, μ(Cu Kα)
= 5.612 mm−1, T = 173 K, colorless blocks, Oxford Diﬀraction
Xcalibur PX Ultra diﬀractometer; 2699 independent measured
reﬂections (Rint = 0.0261), F
2 reﬁnement, R1(obs) = 0.0196,
wR2(all) = 0.0431, 2400 independent observed absorption-corrected
reﬂections [|F0| > 4σ(|F0|), 2θmax = 143°], 164 parameters. The
absolute structure of 9 was determined by a combination of R-factor
tests [R1
+ = 0.0196, R1
− = 0.0338] and by use of the Flack parameter
[x+ = 0.000(13), x− = 1.013(13)]. CCDC: 1455995. Z-macrocycle Z-9
(2.0 mg, 11%) was isolated as a white solid: Rf 0.22 (toluene); mp
133−135 °C; [α]D28 +8.0 (c 0.54, CH2Cl2); IR (neat) 2971, 2934,
2899, 1660, 1447, 1378, 1292, 1270, 1072 cm−1; 1H NMR (400 MHz,
CDCl3) δ 5.58 (dd, J = 10.9, 9.1 Hz, 1H), 5.51 (td, J = 10.5, 6.1 Hz,
1H), 4.60 (dq, J = 8.9, 6.2 Hz, 1H), 4.47 (dt, J = 11.5, 5.7 Hz, 1H),
4.40 (dt, J = 10.1, 6.8 Hz, 1H), 4.33 (t, J = 8.0 Hz, 1H), 4.22 (d, J = 9.2
Hz, 1H), 3.98 (ddd, J = 12.5, 3.6, 1.3 Hz, 1H), 3.15 (td, J = 12.7, 10.5
Hz, 1H), 2.57 (dtd, J = 13.4, 7.2, 3.7 Hz, 2H), 2.37 (ddd, J = 15.4,
11.4, 9.5 Hz, 1H), 2.15−2.04 (m, 2H), 1.38 (d, J = 6.1 Hz, 3H);
13C{1H} NMR (101 MHz, CDCl3) δ 135.3, 128.4, 119.6, 77.8, 77.2,
73.5, 65.0, 55.6, 53.9, 38.2, 35.4, 35.0, 19.8; MS (CI+, NH3) m/z 351,
353, 355 (M + NH4)
+; HRMS (ESI+, TOF) m/z [M + H]+ calcd for
C13H18NO2
35Cl79Br 334.0209, found 334.0202.
(1R,3R,5S,6E,9S,10S,12R)-9-Bromo-12-chloro-5-methyl-4,13-
dioxabicyclo[8.2.1]tridec-6-ene-3-carbonitrile (10). Toluene (160
mL) was reﬂuxed in a Dean−Stark apparatus for 1 h. The ﬂask was
removed from the hot plate and allowed to cool before diene 11 (20
mg, 0.055 mmol) and Hoveyda−Grubbs II catalyst22b (10.4 mg, 30
mol %) were added. The ﬂask was covered with aluminum foil, and the
orange solution was returned to reﬂux for 18 h. The ﬂask was removed
from the hot plate and allowed to cool before di(ethylene glycol) vinyl
ether (6 μL) was added. The solvent was removed in vacuo to give a
brown oil. Column chromatography (toluene) gave the E-macrocycle
10 (10.0 mg, 54%) as white crystals: Rf 0.13 (toluene); mp 144 °C;
[α]D
18 +18.4 (c 0.46, CH2Cl2); IR (neat) 2932, 2253, 1665, 1449,
1386, 1091, 1060 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.90−5.77 (m,
1H), 5.72−5.59 (m, 1H), 4.72 (td, J = 8.1, 5.4 Hz, 1H), 4.54−4.44 (m,
2H), 4.43−4.38 (m, 1H), 4.37−4.29 (m, 1H), 3.92−3.77 (m, 1H),
2.93−2.84 (m, 1H), 2.55−2.35 (m, 3H), 1.95−1.89 (m, 2H), 1.42 (d, J
= 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 129.7, 126.6,
119.6, 78.3, 75.3, 71.8, 61.4, 56.6, 49.2, 38.9, 37.6, 36.3, 13.5; MS (CI+,
NH3) m/z 334, 336, 338 (M + H)
+; HRMS (CI+, magnetic sector) m/
z [M + H]+ calcd for C13H18NO2
35Cl79Br 334.0209, found 334.0212.
Crystal data for 10: C13H17BrClNO2, M = 334.64, orthorhombic,
P212121 (no. 19), a = 9.90540(9) Å, b = 16.30560(13) Å, c =
17.66934(16) Å, V = 2853.84(4) Å3, Z = 8 (two independent
molecules), Dc = 1.558 g cm
−3, μ(Cu Kα) = 5.607 mm−1, T = 173 K,
colorless tablets, Oxford Diﬀraction Xcalibur PX Ultra diﬀractometer;
5605 independent measured reﬂections (Rint = 0.0374), F
2 reﬁnement,
R1(obs) = 0.0310, wR2(all) = 0.0746, 5086 independent observed
absorption-corrected reﬂections [|F0| > 4σ(|F0|), 2θmax = 145°], 325
parameters. The absolute structure of 10 was determined by a
combination of R-factor tests [R1
+ = 0.0310, R1
− = 0.0422] and by use




trioxatricyclo[9.2.1.04,6]tetradecane-9-carbonitrile (26). To a solu-
tion of E-macrocycle 10 (25.0 mg, 0.0747 mmol) in CH2Cl2 (830 μL)
was added m-CPBA (25.8 mg, 75%, 0.112 mmol). The colorless
solution was stirred for 2 h until TLC (n-hexane/Et2O 2:1) showed
completion of the reaction. The reaction was quenched with 10%
Na2SO3 (1 mL) and stirred for an additional 5 min. The mixture was
extracted with CH2Cl2 (3 × 3 mL), the organic layers washed with
satd aq NaHCO3 solution (2 × 5 mL), dried over Na2SO4, and
ﬁltered, and the solvent was removed in vacuo to give a cloudy oil
(37.8 mg). Column chromatography (n-hexane/Et2O 2:1) gave
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epoxide 26 (19.0 mg, 0.0542 mmol, 73%) and epoxide 25 (6.8 mg,
0.0194 mmol, 26%) as colorless oils. Epoxide 26: Rf 0.17 (n-hexane/
EtOAc 2:1); IR 2926, 1681, 1262, 1090, 927 cm−1; 1H NMR (400
MHz, CDCl3) δ 4.76 (dt, J = 9.8, 6.3 Hz, 1H), 4.60 (dd, J = 10.3, 3.1
Hz, 1H), 4.63−4.56 (m, 1H), 4.47 (ddd, J = 13.0, 6.0, 3.2 Hz, 1H),
4.43 (ddd, J = 4.4, 2.4, 1 Hz, 1H), 4.17 (dt, J = 10.8, 2.6 Hz, 1H), 3.13
(dd, J = 8.7, 2.1 Hz, 1H), 3.00 (dd, J = 3.6, 2.2 Hz, 1H), 2.63 (dd, J =
15.1, 3.0 Hz, 1H), 2.52 (dd, J = 14.5, 6.8 Hz, 1H), 2.43 (ddd, J = 14.4,
9.8, 4.4 Hz, 1H), 2.15−2.09 (m, 2H), 1.86 (ddd, J = 15.1, 12.5, 8.6 Hz,
1H), 1.17 (d, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ
119.1, 77.8, 77.7, 73.2, 61.0, 60.3, 58.1, 53.6, 46.3, 39.2, 36.6, 35.5, 9.9;
HRMS (ES+, TOF) m/z [M + H]+ calcd for C13H18NO3
35Cl79Br
350.0153, found 350.0152. Epoxide 25: Rf 0.16 (n-hexane/EtOAc
2:1); IR 2926, 1671, 1263, 1087, 948 cm−1; 1H NMR (400 MHz,
CDCl3) δ 4.65 (dd, J = 11.4, 3.4 Hz, 1H), 4.58 (dd, J = 6.3, 3.4 Hz,
1H), 4.54−4.45 (m, 2H), 4.31 (ddd, J = 7.2, 3.1, 1.6 Hz, 1H), 3.48−
3.38 (m, 2H), 3.04 (dd, J = 8.7, 2.1 Hz, 1H), 2.99 (dt, J = 14.7, 6.3 Hz,
1H), 2.78 (ddd, J = 14.5, 7.2, 2.5 Hz, 1H), 2.54 (ddd, J = 14.8, 7.7, 1.2
Hz, 1H), 2.34 (ddd, J = 13.6, 9.9, 3.3 Hz, 1H), 2.14 (ddd, J = 14.1,
11.4, 4.4 Hz, 1H), 1.75 (ddd, J = 14.6, 8.3, 1.6 Hz, 1H), 1.59 (d, J = 6.8
Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 125.5, 79.4, 78.3, 76.4,
62.0, 61.1, 59.8, 57.3, 54.3, 43.0, 36.9, 35.1, 17.2; HRMS (ES+, TOF)





(27). To a stirred solution of epoxynitrile 26 (6.8 mg, 0.019 mmol) in
THF (300 μL) at −78 °C was added DIBAL-H in THF (34 μL, 0.86
M, 0.029 mmol), and the colorless solution was warmed to 0 °C and
stirred for 30 min until TLC (toluene/MeCN 9:1) showed completion
of the reaction. The reaction was quenched with a 1 M aqueous citric
acid solution (1 mL) and stirred for 15 min. The mixture was extracted
with CH2Cl2 (3 × 3 mL), the organic layer was dried over Na2SO4,
and the solvent removed in vacuo to give the desired aldehyde as white
solid (6.8 mg) which was carried through to the next step without
further puriﬁcation. To a stirred solution of the crude aldehyde (6.8
mg) in THF (200 μL) at 0 °C was added ethynylmagnesium bromide
in THF (57 μL, 0.5 M, 0.029 mmol), and the yellow solution was
stirred for 30 min until TLC (n-hexane/EtOAc 1:1) showed
completion of the reaction. The reaction was quenched with satd aq
NH4Cl (1 mL) and stirred for 5 min. The mixture was extracted with
CH2Cl2 (3 × 3 mL), the organic layer was dried over Na2SO,4 and the
solvent was removed in vacuo to give a yellow oil (10.8 mg). Column
chromatography (n-hexane/EtOAc 2:1) gave compound epi-alcohol
27 (1.8 mg, 0.0047 mmol, 25%) and compound 27 (1.9 mg, 0.0050
mmol, 26%) as colorless oils. epi-Alcohol 27: Rf 0.12 (n-hexane/EtOAc
2:1); 1H NMR (400 MHz, CDCl3) δ 4.78 (dt, J = 9.6, 6.5 Hz, 1H),
4.56 (qd, J = 7.2, 3.2 Hz, 1H), 4.49 (ddd, J = 12.8, 5.7, 2.9 Hz, 1H),
4.43 (dd, J = 4.2, 2.4 Hz, 1H), 4.28−4.22 (m, 2H), 3.96 (ddd, J = 11.2,
4.7, 1.8 Hz, 1H), 3.14 (dd, J = 8.8, 2.2 Hz, 1H), 3.09 (t, J = 3.2, 2.3 Hz,
1H), 2.63 (dd, J = 14.9, 2.9 Hz, 1H), 2.51 (d, J = 2.2 Hz, 1H), 2.50
(dd, J = 11.8, 6.9 Hz, 1H), 2.43 (td, J = 9.8, 4.8 Hz, 1H), 2.23 (d, J =
6.0 Hz, 1H), 2.02 (ddd, J = 13.5, 10.8, 1.9 Hz, 1H), 1.89 (ddd, J =
15.4, 12.9, 9.1 Hz, 1H), 1.80 (ddd, J = 13.7, 11.2, 2.1 Hz, 1H), 1.12 (d,
J = 7.1 Hz, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 82.3, 78.8, 78.0,
74.7, 72.3, 70.3, 65.6, 62.5, 61.5, 54.3, 46.9, 38.8, 35.4, 33.1, 10.5.
Alcohol 27: Rf 0.07 (n-hexane/EtOAc 2:1);
1H NMR (400 MHz,
CDCl3) δ 4.78 (dt, J = 9.7, 6.3 Hz, 1H), 4.58 (qd, J = 7.3, 3.3 Hz, 1H),
4.49 (ddd, J = 12.6, 5.6, 2.9 Hz, 1H), 4.43 (dd, J = 4.3, 2.1 Hz, 1H),
4.38 (ddd, J = 5.4, 3.1, 2.3 Hz, 1H), 4.24 (dt, J = 10.9, 2.2 Hz, 1H),
4.01 (ddd, J = 11.3, 2.8, 1.7 Hz, 1H), 3.14 (dd, J = 8.8, 2.2 Hz, 1H),
3.09 (dd, J = 3.3, 2.3 Hz, 1H), 2.63 (dd, J = 14.9, 2.9 Hz, 1H), 2.54 (d,
J = 2.2 Hz, 1H), 2.50 (dd, J = 14.4, 6.8 Hz, 1H), 2.43 (ddd, J = 14.3,
9.6, 4.4 Hz, 1H), 2.24 (d, J = 5.5 Hz, 1H), 1.99 (ddd, J = 14.2, 10.9, 1.9
Hz, 1H), 1.92−1.81 (m, 2H), 1.08 (d, J = 7.1 Hz, 3H); 13C{1H} NMR
(126 MHz, CDCl3) δ 81.1, 79.0, 78.0, 75.3, 72.3, 70.6, 66.0, 62.4, 61.5,
54.2, 46.9, 38.9, 35.4, 32.1, 10.5; HRMS (ES+, TOF) m/z [M + H]+
calcd for C15H21O4
35Cl79Br 379.0312, found 379.0316.
(1S)-1-[(1S,2S,4R,6R,7S,9R,11R,12R)-2-Bromo-12-chloro-7-meth-
yl-5,8,14-trioxatricyclo[9.2.1.04,6]tetradecan-9-yl]prop-2-yn-1-yl
2,4,6-tris(propan-2-yl)benzene-1-sulfonate (28). To alcohol 27 (5.0
mg, 0.013 mmol) was added a solution of TrisCl and DMAP in
CH2Cl2 (440 μL, 0.038 M, 0.017 mmol of each). The colorless
solution was stirred for 20 h, a further aliquot of TrisCl and DMAP in
CH2Cl2 (200 μL, 0.038 M, 0.0076 mmol of each) was added, and
stirring was resumed for 4 h until TLC (n-hexane/EtOAc 2:1) showed
completion of the reaction. The solution was passed through a plug of
silica, eluting with n-hexane/EtOAc 2:1. The solvent was removed in
vacuo to give a white solid (12.6 mg). Column chromatography (n-
hexane/EtOAc 7:1) gave the title compound 28 (5.5 mg, 0.0085
mmol, 65%) as a white solid: Rf 0.58 (n-hexane/EtOAc 2:1);
1H NMR
(400 MHz, CDCl3) δ 7.16 (s, 2H), 5.07 (t, J = 2.5 Hz, 1H), 4.76 (dt, J
= 9.7, 6.3 Hz, 1H), 4.51−4.44 (m, 2H), 4.39 (dd, J = 4.1, 2.2 Hz, 1H),
4.22 (dt, J = 11.0, 2.2 Hz, 1H), 4.18−4.10 (m, 3H), 3.11 (dd, J = 8.8,
2.2 Hz, 1H), 3.04 (dd, J = 3.1, 2.3 Hz, 1H), 2.90 (hept, J = 7.3 Hz,
1H), 2.62 (dd, J = 14.8, 2.9 Hz, 1H), 2.49 (dd, J = 14.5, 6.9 Hz, 1H),
2.42 (ddd, J = 14.3, 9.6, 4.4 Hz, 1H), 2.32 (d, J = 2.3 Hz, 1H), 1.93
(ddd, J = 12.6, 10.8, 1.7 Hz, 1H), 1.93−1.72 (m, 3H), 1.32−1.21 (m,
18H), 1.06 (d, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ
153.9, 150.8, 123.6, 110.0, 78.6, 78.0, 77.9, 77.2, 72.9, 72.4, 69.9, 62.2,
61.4, 54.1, 46.8, 38.9, 35.4, 34.3, 32.9, 29.7, 24.8, 24.6, 23.6, 23.6, 10.2;





tetradecane, 12-Epoxyobtusallene IV (7). LiBr (11.4 mg, 0.131
mmol) and CuBr (18.8 mg, 0.131 mmol) were stirred at room
temperature in CH2Cl2 (1.20 mL) for 1 h, during which time the salts
dissolved and turned bright green. To a stirred solution of trisylate 28
(5.5 mg, 0.0085 mmol) in CH2Cl2 (300 μL) was added the LiCuBr2
solution (235 μL, 0.109 M, 0.0256 mmol). The green solution was
heated to 60 °C and stirred for 2.5 h, until TLC (n-hexane/EtOAc
2:1) showed completion of the reaction. The solution was passed
through a plug of silica, eluting with n-hexane/EtOAc 2:1. The solvent
was removed in vacuo to give a white solid (3.3 mg). Column
chromatography (toluene) gave title compound 7 (3.8 mg, 0.0085
mmol, quant, 94:6 dr) as a white solid: Rf 0.52 (n-hexane/EtOAc 2:1);
1H NMR (400 MHz, CDCl3) δ 6.04 (dd, J = 5.7, 1.7 Hz, 1H), 5.37
(dd, J = 6.5, 5.7 Hz, 1H), 4.76 (dt, J = 9.7, 6.3 Hz, 1H), 4.54 (qd, J =
6.9, 3.7 Hz, 1H), 4.49 (ddd, J = 12.7, 5.9, 2.9 Hz, 1H), 4.45 (ddt, J =
11.0, 6.4, 1.8, 1.7 Hz, 1H), 4.42 (dd, J = 4.0, 2.1 Hz, 1H), 4.26 (dt, J =
10.8, 2.2 Hz, 1H), 3.18 (dd, J = 8.6, 2.2 Hz, 1H), 3.04 (dd, J = 3.7, 2.3
Hz, 1H), 2.64 (dd, J = 14.9, 3.0 Hz, 1H), 2.48 (dd, J = 14.4, 6.9 Hz,
1H), 2.43 (ddd, J = 14.3, 9.7, 4.3 Hz, 1H), 1.89 (ddd, J = 15.0, 12.7,
8.7 Hz, 1H), 1.86 (ddd, J = 13.9, 10.5, 2.0 Hz, 1H), 1.74 (ddd, J =
13.8, 11.0, 2.1 Hz, 1H), 1.08 (d, J = 7.1 Hz, 3H); 13C{1H} NMR (101
MHz, CDCl3) δ 201.0, 103.3, 78.9, 77.7, 73.9, 72.1, 66.4, 62.0, 61.5,
53.9, 46.9, 39.0, 37.7, 35.7, 10.2; HRMS (ES+, TOF) m/z [M + H]+
calcd for C15H20O3
35Cl79Br2 440.9468, found 440.9464. There was
insuﬃcient material to record a melting point or rotation to compare
with the literature values.
(1R,3R,5S,6R,7R,9S,10S,12R)-7,9-Dibromo-3-[(Sa)-3-bromopropa-
1,2-dien-1-yl]-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridecan-
6-ol, Obtusallene X (8). To a sample of 12-epoxyobtusallene IV (7)
(2.0 mg, 0.0043 mmol) in dichloromethane (200 μL) was added
hydrobromic acid in water (0.97 μL, 48%, 0.0086 mmol) and the
mixture stirred in the dark for 1 h until TLC (n-hexane/EtOAc 2:1)
showed completion of the reaction. The reaction was quenched with
satd aq NaHCO3 solution (1 mL) and stirred for 5 min. The mixture
was partitioned between water (1 mL) and CH2Cl2 (3 mL), separated,
and extracted further with CH2Cl2 (2 × 3 mL). The organic layer was
dried over Na2SO4 and the solvent removed in vacuo to give a
colorless oil (4.1 mg). Column chromatography (n-hexane/EtOAc
6:1) gave title compound 8 (2.2 mg, 0.042 mmol, 93%) as a colorless
oil: Rf 0.33 (n-hexane/EtOAc 2:1);
1H NMR (500 MHz, CDCl3) δ
6.03 (dd, J = 5.6, 0.9 Hz, 1H), 5.73 (dd, J = 8.9, 5.6 Hz, 1H), 4.62−
4.53 (m, 3H), 4.48−4.42 (m, 2H), 4.39 (dt, J = 11.3, 5.0, 4.1 Hz, 1H),
4.18 (qd, J = 6.6, 3.2 Hz, 1H), 3.92 (d, J = 3.4 Hz, 1H), 3.69 (dd, J =
6.5, 3.4 Hz, 1H), 2.87 (dd, J = 15.5, 12.1 Hz, 1H), 2.65 (ddd, J = 15.3,
9.3, 2.4 Hz, 1H), 2.53 (ddd, J = 13.7, 9.6, 7.6 Hz, 1H), 2.37 (ddd, J =
The Journal of Organic Chemistry Featured Article
DOI: 10.1021/acs.joc.6b02008
J. Org. Chem. 2016, 81, 9539−9552
9548
14.7, 11.3, 2.1 Hz, 1H), 2.25 (ddd, J = 13.7, 5.5, 0.9 Hz, 1H), 1.72
(ddd, J = 14.8, 7.3, 3.9 Hz, 1H), 1.36 (d, J = 6.6 Hz, 3H); 13C{1H}
NMR (126 MHz, CDCl3) δ 202.2, 100.0, 76.5, 76.4, 74.2, 73.5, 72.6,
70.4, 59.7, 58.1, 48.5, 43.6, 41.3, 35.3, 13.0. HRMS (ES+, TOF) m/z
(M + H)+ calcd for C15H21O3
35Cl79Br3 520.8724, found 520.8725.
There was insuﬃcient material to record an optical rotation.
(1S,2S,4S,6S,7S,9S,11R,12R)-2-Bromo-12-chloro-7-methyl-5,8,14-
trioxatricyclo[9.2.1.04,6]tetradecane-9-carbonitrile (29). To a solu-
tion of E-macrocycle 9 (22.5 mg, 0.0672 mmol) in CH2Cl2 (400 μL)
was added m-CPBA (23.2 mg, 75%, 0.101 mmol). The colorless
solution was stirred for 2 h until TLC (n-hexane/EtOAc 4:1) showed
completion of the reaction. The reaction was quenched with 20%
Na2SO3 (1 mL) and stirred for an additional 5 min. The mixture was
extracted with CH2Cl2 (3 × 3 mL), the organic layers washed with
satd aq NaHCO3 (2 × 3 mL), dried over Na2SO4, and ﬁltered, and the
solvent was removed in vacuo to give a colorless oil (26.2 mg).
Column chromatography (n-hexane/EtOAc 4:1) gave epoxide 29
(22.8 mg, 0.0439 mmol, 97%) as a colorless oil: Rf 0.15 (n-hexane/
EtOAc 4:1); IR (neat) 2926, 1673, 1260, 1090, 927 cm−1; 1H NMR
(400 MHz, CDCl3) δ 4.51 (dd, J = 5.1, 3.0 Hz, 1H), 4.42 (dt, J = 11.0,
3.2 Hz, 1H), 4.37−4.32 (m, 3H), 3.36 (dt, J = 9.4, 2.1 Hz, 1H), 3.22
(dq, J = 8.4, 6.4 Hz, 1H), 2.84 (ddd, J = 14.6, 4.5, 2.0 Hz, 1H), 2.76−
2.67 (m, 2H), 2.50 (ddd, J = 14.8, 11.1, 8.9 Hz, 1H), 2.42 (dd, J =
14.2, 6.4 Hz, 1H), 2.00 (ddd, J = 14.7, 3.4, 0.9 Hz, 1H), 1.67 (ddd, J =
14.7, 9.4, 2.5 Hz, 1H), 1.42 (d, J = 6.4 Hz, 3H); 13C{1H} NMR (101
MHz, CDCl3) δ 119.1, 82.7, 81.5, 79.2, 69.6, 62.5, 61.5, 58.5, 55.1,
42.8, 39.9, 37.0, 19.7; MS (CI+, NH3) m/z 350, 352, 354 (M + H)
+;
HRMS (CI+, NH3) m/z [M + H]





(30). To a solution of epoxide 29 (5.0 mg, 0.014 mmol) in MeOH
(200 μL) was added CSA (0.33 mg, 0.0014 mmol), and the cloudy
suspension was stirred for 2 h. A further quantity of CSA was added
(0.33 mg, 0.0014 mmol) and stirring continued for 2 h until TLC (n-
hexane/EtOAc 2:1) showed completion of the reaction. Water (1 mL)
was added to the reaction mixture, which was then extracted with
CH2Cl2 (3 × 3 mL), dried over Na2SO4, and ﬁltered, solvent was
removed in vacuo, and the product was chromatographed (n-hexane/
EtOAc 2:1) to give compound 30 (5.0 mg, 0.0439 mmol, 93%) as a
colorless oil: Rf 0.08 (n-hexane/EtOAc 2:1); [α]D −0.09 (c 0.24,
MeOH/CHCl3 1:1); IR 3357, 2923, 1641, 1082 cm
−1; 1H NMR (400
MHz, CD3OD: CDCl3 1:1) δ 4.82 (t, J = 3.8 Hz, 1H), 4.70 (dd, J =
11.9, 2.0 Hz, 1H), 4.21 (dt, J = 5.9, 1.7 Hz, 1H), 4.03 (d, J = 7.1 Hz,
1H), 3.95 (d, J = 11.0 Hz, 1H), 3.71 (t, J = 10.0 Hz, 1H), 3.58 (dq, J =
9.3, 6.3 Hz, 1H), 3.36 (s, 3H), 3.07 (t, J = 9.2 Hz, 1H), 2.92 (ddd, J =
16.2, 7.2, 1.8 Hz, 1H), 2.60 (ddd, J = 15.2, 4.2, 1.3 Hz, 1H), 2.36 (ddd,
J = 14.3, 11.9, 10.7 Hz, 1H), 2.19 (ddd, J = 15.2, 10.7, 3.5 Hz, 1H),
2.12 (dd, J = 16.2, 5.6 Hz, 1H), 1.69 (dt, J = 14.5, 1.7 Hz, 1H), 1.35 (d,
J = 6.2 Hz, 3H); 13C{1H} NMR (101 MHz, CD3OD: CDCl3 1:1) δ
118.3, 86.8, 85.4, 84.5, 79.2, 73.4, 71.5, 63.3, 60.4, 55.7, 42.1, 40.3,
38.3, 19.8; HRMS (ES−, TOF) m/z [M + HCO2]
− calcd for
C15H22NO6
35Cl79Br 426.0319, found 426.0319.
(1R)-1-[(1S,2S,4S,6S,7S,9S,11R,12R)-2-Bromo-12-chloro-7-methyl-
5,8,14-trioxatricyclo[9.2.1.04,6]tetradecan-9-yl]prop-2-yn-1-ol (31).
To a stirred solution of nitrile 29 (21.0 mg, 0.0599 mmol) in THF
(300 μL) at −78 °C was added DIBAL-H in THF (105 μL, 0.86 M,
0.0898 mmol), and the colorless solution was warmed to −40 °C.
After 30 min, a further aliquot of DIBAL-H in THF (105 μL, 0.86 M,
0.0898 mmol) was added and the mixture stirred for an additional 30
min until TLC (n-hexane/EtOAc 1:1) showed completion of the
reaction. The reaction was quenched with a 1 M aqueous citric acid
solution (1 mL) and stirred for 15 min. The mixture was extracted
with CH2Cl2 (3 × 3 mL), the organic layer was dried over Na2SO4,
and the solvent was removed in vacuo to give the desired aldehyde as a
white solid (10.5 mg) that was carried through to the next step
without further puriﬁcation. To a stirred solution of the crude
aldehyde (10.5 mg) in THF (300 μL) at 0 °C was added
ethynylmagnesium bromide in THF (89 μL, 0.5 M, 0.0447 mmol)
and the yellow solution stirred for 30 min. A second aliquot of
ethynylmagnesium bromide in THF (100 μL, 0.5 M, 0.0500 mmol)
was added and the mixture stirred for an additional 1 h. A third aliquot
of ethynylmagnesium bromide in THF (100 μL, 0.5 M, 0.0500 mmol)
was added and stirred for an additional 30 min until TLC (n-hexane/
EtOAc 1:1) showed completion of the reaction. The reaction was
quenched with satd aq NH4Cl (1 mL) and stirred for 5 min. The
mixture was extracted with CH2Cl2 (3 × 3 mL), the organic layer was
dried over Na2SO4, and the solvent was removed in vacuo to give a
yellow oil (12.4 mg). Column chromatography (toluene/MeCN 9:1)
gave title compound 31 (7.0 mg, 0.018 mmol, 31%, 3:1 dr) as a
colorless oil: Rf 0.09 (toluene/ MeCN 9:1);
1H NMR (400 MHz,
CDCl3) δ 4.51 (dd, J = 5.3, 3.0 Hz, 1H), 4.45−4.35 (m, 3H), 4.32 (td,
J = 4.7, 2.2 Hz, 0.77H), 4.19 (ddd, J = 7.1, 4.7, 2.2 Hz, 0.23H), 3.72
(dd, J = 8.3, 4.7 Hz, 0.25H), 3.67 (dd, J = 8.1, 4.8 Hz, 0.75H), 3.43 (dt,
J = 9.3, 2.1 Hz, 1H), 3.32 (dq, J = 8.2, 6.4 Hz, 0.25H), 3.24 (dq, J =
8.4, 6.4 Hz, 0.76H), 2.84 (ddd, J = 14.6, 4.8, 2.0 Hz, 1H), 2.77 (dd, J =
8.3, 2.3 Hz, 1H), 2.74 (ddd, J = 13.8, 8.4, 5.1 Hz, 1H), 2.49 (d, J = 2.2
Hz, 0.61H), 2.47 (d, J = 2.2 Hz, 0.20H), 2.41 (dd, J = 14.1, 6.5 Hz,
1H), 2.23 (d, J = 4.7 Hz, 0.67H), 2.05 (ddd, J = 14.6, 11.0, 8.1 Hz,
1H), 1.92 (dd, J = 14.3, 2.7 Hz, 0.75H), 1.77 (dd, J = 14.6, 2.6 Hz,
0.24H), 1.70 (ddd, J = 14.6, 9.3, 2.3 Hz, 1H), 1.42 (d, J = 6.4 Hz,
0.73H), 1.40 (d, J = 6.4 Hz, 2.27H); 13C{1H} NMR (101 MHz,
CDCl3) δ 84.7, 83.0, 81.4, 79.1, 77.2, 74.6, 65.9, 63.4, 62.4, 58.9, 55.6,
42.8, 39.9, 32.9, 20.5; HRMS (ES+, TOF) m/z [M + H]+ calcd for
C15H21O4
79Br35Cl 379.0307, found 379.0306. The alcohol dr was
established by integration of the C3 proton resonances at 3.72 ppm
(minor) and 3.67 ppm (major).
(1S,2S,4S,6S,7S,9S,11R,12R)-2-Bromo-9-[(Ra)-3-bromopropa-1,2-
dien-1-yl]-12-chloro-7-methyl-5,8,14-trioxatricyclo[9.2.1.04,6]-
tetradecane, 12-Epoxyobtusallene II (32). To a stirred solution of
alcohol 31 (5.9 mg, 0.016 mmol, 3:1 dr) in CH2Cl2 (200 μL) was
added a solution of TrisCl and DMAP in CH2Cl2 (253 μL, 0.0613 M,
0.0155 mmol of each). The colorless solution was stirred for 17 h until
TLC (n-hexane/EtOAc 2:1) showed completion of the reaction. The
solution was passed through a plug of silica, eluting with n-hexane/
EtOAc 2:1. The solvent was removed in vacuo to give a white solid
(6.2 mg). Column chromatography (n-hexane/EtOAc 25:1) gave the
corresponding trisylate (6.2 mg, 0.0096 mmol, 62%, 3:1 dr) as a white
solid: Rf 0.43 (n-hexane/EtOAc 2:1);
1H NMR (400 MHz, CDCl3) δ
7.17 (s, 2H), 5.03 (dd, J = 4.7, 2.2 Hz, 0.75H), 5.01 (dd, J = 5.7, 2.2
Hz, 0.25H), 4.49 (dd, J = 5.1, 2.8 Hz, 1H), 4.40−4.32 (m, 3H), 4.13
(hept, J = 6.7 Hz, 2H), 3.83 (dd, J = 7.9, 4.7 Hz, 0.75H), 3.79 (dd, J =
7.9, 5.9 Hz, 0.25H), 3.39 (dt, J = 9.4, 2.2 Hz, 1H), 3.21 (dq, J = 7.9, 6.3
Hz, 0.75H), 3.16 (dq, J = 7.8, 6.3 Hz, 0.25H), 2.91 (hept, J = 7.4 Hz,
1H), 2.82 (ddd, J = 14.7, 4.7, 2.0 Hz, 1H), 2.76−2.68 (m, 2H), 2.39
(dd, J = 14.1, 6.4 Hz, 1H), 2.32 (d, J = 2.2 Hz, 0.76H), 2.26 (d, J = 2.2
Hz, 0.25H), 2.13−2.03 (m, 1H), 1.87 (dd, J = 14.4, 2.8 Hz, 0.25H),
1.81 (dd, J = 14.5, 2.9 Hz, 0.75H), 1.66 (ddd, J = 14.6, 9.4, 2.3 Hz,
1H), 1.36 (d, J = 6.4 Hz, 0.73H), 1.30−1.23 (m, 21H); 13C{1H} NMR
(101 MHz, CDCl3) δ 174.8, 154.0, 150.9, 123.7, 83.0, 82.5, 81.9, 79.1,
77.2, 76.9, 72.2, 63.3, 62.2, 58.8, 55.5, 42.8, 40.0, 34.3, 33.7, 29.7, 24.8,
24.7, 24.6, 23.6, 19.7. LiBr (11.4 mg, 0.131 mmol) and CuBr (18.8 mg,
0.131 mmol) were dissolved in CH2Cl2 (1.20 mL). The mixture was
stirred at room temperature for 1 h, during which time the salts
dissolved and turned bright green. To a stirred solution of the above
trisylate (6.2 mg, 0.0096 mmol, 3:1 dr) in CH2Cl2 (300 μL) was added
the LiCuBr2 solution (265 μL, 0.109 M, 0.0289 mmol). The green
solution was heated to 60 °C and stirred for 4 h until TLC (n-hexane/
EtOAc 2:1) showed completion of the reaction. The solution was
passed through a plug of silica, eluting with n-hexane/EtOAc 2:1. The
solvent was removed in vacuo and chromatographed (toluene to
toluene/MeCN 50:1) to give title compound 32 (3.6 mg, 0.0096
mmol, 85%, 3:1 dr) as a white solid: Rf 0.52 (n-hexane/EtOAc 2:1);
1H NMR (400 MHz, CDCl3) δ 6.08 (dd, J = 5.7, 2.0 Hz, 0.18H), 6.04
(dd, J = 5.7, 1.7 Hz, 0.54H), 5.43 (t, J = 5.9 Hz, 0.60H), 5.41 (t, J = 5.8
Hz, 0.20H), 4.53 (dd, J = 5.5, 3.1 Hz, 0.24H), 4.50 (dd, J = 5.3, 3.0 Hz,
0.76H), 4.46−4.32 (m, 3H), 4.18 (ddd, J = 7.9, 6.0, 1.7 Hz, 0.75H),
4.13 (td, J = 6.8, 2.1 Hz, 0.25H), 3.43 (dt, J = 9.4, 2.2 Hz, 1H), 3.17−
3.07 (m, 1H), 2.83 (ddd, J = 14.5, 4.8, 1.9 Hz, 1H), 2.79−2.71 (m,
2H), 2.42 (ddd, J = 14.1, 6.6, 0.7 Hz, 1H), 2.24−2.15 (m, 1H), 1.75−
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1.65 (m, 2H), 1.38 (d, J = 6.3 Hz, 0.75H), 1.37 (d, J = 6.4 Hz, 2.25H);
13C{1H} NMR (101 MHz, CDCl3) δ 200.7, 103.1, 82.7, 81.0, 79.9,
79.1, 73.7, 63.5, 62.3, 58.7, 56.0, 42.8, 39.8, 37.1, 20.3; MS (ES+, TOF)
m/z 441, 443, 445, 447 [M + H]+; HRMS (ES+, TOF) m/z [M + H]+
calcd for C15H20O3
35Cl79Br2 440.9468, found 440.9458. The
bromoallene dr was established by integration of the C1 proton
resonances at 6.08 ppm (minor) and 6.04 ppm (major). Approx-
imately 15% of the mixture consisted also of inseparable propargylic
bromides in a 3:2 ratio as calculated by comparison of the integral of
the C15-methyl protons. The observable peaks are given here:
1H
NMR (400 MHz, CDCl3) δ 5.03 (td, J = 4.5, 2.2 Hz, 0.13H), 3.85−
3.77 (m, 0.30H), 3.34−3.20 (m, 0.30H), 2.66 (d, J = 2.4 Hz, 0.06H),




[5.5.1]tridecan-2-ol, Marilzabicycloallene C (5). To a sample of
epoxide 32 (2.0 mg, 0.0045 mmol) was added a solution of CSA in
MeOH (100 μL, 0.0043 μM, 0.00043 mmol) and the suspension
stirred for 1 h. An additional aliquot of CSA in MeOH (100 μL,
0.0043 μM, 0.00043 mmol) was added and stirring resumed for 1 h
until TLC (n-hexane/EtOAc 2:1) showed completion of the reaction.
The reaction was quenched with satd aq NaHCO3 (1 mL) and stirred
for 5 min. The mixture was partitioned between water (1 mL) and
CH2Cl2 (3 mL), separated, and extracted further with CH2Cl2 (2 × 3
mL). The organic layer was dried over Na2SO4 and the solvent
removed in vacuo to give a white solid (2.5 mg). Column
chromatography (n-hexane/EtOAc 4:1 to 2:1) gave title compound
5 (2.0 mg, 0.042 mmol, 94%, 3:1 dr) as a white solid: Rf 0.19 (n-
hexane/EtOAc 2:1); 1H NMR (500 MHz, CDCl3) δ 6.09 (dd, J = 5.7,
2.2 Hz, 0.18H), 6.05 (dd, J = 5.7, 2.1 Hz, 0.54H), 5.47 (t, J = 5.5 Hz,
0.60H), 5.40 (t, J = 5.3 Hz, 0.20H), 4.85 (t, J = 3.9 Hz, 1H), 4.33 (ddt,
J = 9.6, 5.0, 2.2 Hz, 1H), 4.18 (dt, J = 5.7, 1.9 Hz, 1H), 4.06 (d, J = 7.2
Hz, 1H), 3.89 (dt, J = 10.9, 1.7 Hz, 1H), 3.74 (t, J = 9.9 Hz, 1H), 3.57
(dq, J = 9.0, 6.1 Hz, 1H), 3.37 (s, 3H), 3.25 (td, J = 9.2, 5.6 Hz, 1H),
2.90 (ddd, J = 16.1, 7.1, 1.9 Hz, 1H), 2.59 (ddd, J = 15.0, 4.1, 1.3 Hz,
1H), 2.27 (ddd, J = 15.6, 10.8, 3.6 Hz, 1H), 2.19 (dd, J = 16.5, 10.6 Hz,
1H), 2.13 (dt, J = 14.5, 10.9 Hz, 1H), 1.52−1.46 (m, 1H), 1.36 (d, J =
6.2 Hz, 0.75H), 1.35 (d, J = 6.2 Hz, 2.25H); 13C{1H} NMR (126
MHz, CDCl3) δ 200.9, 103.2, 86.7, 85.1, 84.5, 81.1, 79.0, 74.7, 74.1,
63.9, 61.0, 56.0, 42.2, 40.4, 38.8, 20.5; HRMS (ES−, TOF) m/z [M +
CHO2]
− calcd for C17H24O6
35Cl79Br2 516.9628, found 516.9639. The
bromoallene dr was established by integration of the C1 proton
resonances at 6.09 ppm (minor) and 6.05 ppm (major).
(1R,3S,5S,6S,7R,9S,10R,12R)-9-Bromo-6,10,12-trichloro-5-methyl-
4,13-dioxabicyclo[5.5.1]tridecane-3-carbonitrile (33). To a solution
of macrocycle 9 (10.0 mg, 0.0299 mmol) in CH2Cl2 (360 μL) were
added TMG (0.1 μL, 0.0008 mmol), TMSCl (4.2 μL, 0.033 mmol),
and NCS (8.0 mg, 0.060 mmol). The colorless solution was stirred for
3 h until TLC (n-hexane/EtOAc 4:1) showed completion of the
reaction. The reaction was quenched with 10% Na2SO3 (1 mL) and
stirred for an additional 5 min. The mixture was extracted with CH2Cl2
(3 × 3 mL), dried over Na2SO4, and ﬁltered and the solvent removed
in vacuo to give a colorless oil (18.0 mg). Column chromatography (n-
hexane/EtOAc 10:1) gave trichloride 33 (10.6 mg, 0.0261 mmol,
87%) as a colorless oil: Rf 0.22 (n-hexane/EtOAc 4:1); IR (neat) 2930,
1677, 1143 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.98−4.92 (m, 2H),
4.53 (dd, J = 11.9, 1.9 Hz, 1H), 4.05 (dt, J = 5.5, 1.9 Hz, 1H), 3.98−
3.88 (m, 2H), 3.74 (dq, J = 9.6, 6.1 Hz, 1H), 3.51 (t, J = 9.7 Hz, 1H),
3.23 (ddd, J = 16.5, 8.1, 2.1 Hz, 1H), 2.78 (ddd, J = 15.0, 4.7, 1.3 Hz,
1H), 2.63 (ddt, J = 16.4, 5.4, 1.1 Hz, 1H), 2.54 (ddd, J = 14.6, 11.9,
10.9 Hz, 1H), 2.33 (ddd, J = 15.1, 10.4, 3.1 Hz, 1H), 1.69 (dt, J = 14.6,
1.7 Hz, 1H), 1.52 (d, J = 6.1 Hz, 3H); 13C{1H} NMR (101 MHz,
CDCl3) δ 117.4, 86.7, 85.3, 84.2, 71.9, 62.6, 62.5, 62.1, 59.6, 45.1, 44.1,




79Br 447.9485, found 447.9480.
(1R)-[(1R,3S,5S,6S,7R,9S,10R,12R)-9-Bromo-6,10,12-trichloro-5-
methyl-4,13-dioxabicyclo[5.5.1]tridecan-3-yl]prop-2-yn-1-ol (34).
To a stirred solution of nitrile 33 (5.0 mg, 0.012 mmol) in THF
(200 μL) at −78 °C was added DIBAL-H in THF (22 μL, 0.86 M,
0.019 mmol), and the colorless solution warmed to room temperature
and stirred for 30 min until TLC (n-hexane/EtOAc 2:1) showed
completion of the reaction. The reaction was quenched with a 1 M
aqueous citric acid solution (2 mL) and stirred for 10 min. The
mixture was extracted with CH2Cl2 (3 × 3 mL), the organic layer was
dried over Na2SO4, and the solvent was removed in vacuo to give the
desired crude aldehyde as a cloudy oil (7.5 mg) which was carried
through to the next step without further puriﬁcation. To a stirred
solution of the crude aldehyde (7.5 mg) in THF (150 μL) at 0 °C was
added ethynylmagnesium bromide in THF (37 μL, 0.5 M, 0.019
mmol) and the yellow solution stirred for 30 min until TLC (n-
hexane/EtOAc 1:1) showed completion of the reaction. The reaction
was quenched with satd aq NH4Cl (1 mL) and stirred for 5 min. The
mixture was extracted with CH2Cl2 (3 × 3 mL), the organic layer was
dried over Na2SO4, and the solvent was removed in vacuo to give a
yellow oil (5.2 mg). Column chromatography (n-hexane/EtOAc 1:1)
gave title compound 34 (4.2 mg, 0.0097 mmol, 79%, 4.5:1 dr) as a
colorless oil: Rf 0.52 (n-hexane/EtOAc 1:1);
1H NMR (400 MHz,
CDCl3) δ 5.05−4.97 (m, 2H), 4.30 (dd, J = 4.9, 2.2 Hz, 0.82H), 4.17
(dd, J = 5.7, 1.7 Hz, 0.18H), 4.11−4.08 (m, 1H), 4.05−3.93 (m, 2H),
3.85−3.74 (m, 2H), 3.58 (t, J = 9.7 Hz, 1H), 3.28 (ddd, J = 16.4, 8.0,
2.0 Hz, 1H), 2.82 (ddd, J = 15.1, 4.7, 1.3 Hz, 1H), 2.65 (ddt, J = 16.4,
5.4, 1.2 Hz, 1H), 2.53 (d, J = 2.2 Hz, 1H), 2.37 (ddd, J = 15.2, 10.4, 3.2
Hz, 1H), 2.20 (dt, J = 14.5, 11.2 Hz, 1H), 1.76−1.67 (m, 1H), 1.54 (d,
J = 6.1 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 86.8, 86.2, 85.2,
84.0, 75.3, 74.8, 68.2, 63.5, 63.0, 63.0, 60.1, 45.3, 44.3, 38.8, 22.1. The
alcohol dr was established by integration of the C3 proton resonances
at 4.30 ppm (major) and 4.17 ppm (minor).
(1R,2S,3S,5S,7R,8R,10R,11S)-11-Bromo-5-[(Ra)-3-bromopropa-
1,2-dien-1-yl]-2,8,10-trichloro-3-methyl-4,13-dioxabicyclo[5.5.1]-
tridecane, Marilzabicycloallene D (6). To a stirred solution of alcohol
34 (2.5 mg, 0.0061 mmol, 4.5:1 dr) in CH2Cl2 (100 μL) was added a
solution of TrisCl and DMAP in CH2Cl2 (100 μL, 0.061 M, 0.0061
mmol of each). The colorless solution was stirred for 17 h until TLC
(n-hexane/EtOAc 2:1) showed completion of the reaction. The
solution was passed through a plug of silica, eluting with n-hexane/
EtOAc 2:1. The solvent was removed in vacuo to give a white solid
(6.2 mg). Column chromatography (n-hexane/EtOAc 25:1) gave the
corresponding trisylate (3.0 mg, 0.0043 mmol, 70%, 4.5:1 dr) as a
white solid: Rf 0.43 (n-hexane/EtOAc 2:1);
1H NMR (400 MHz,
CDCl3) δ 7.20 (s, 2H), 5.04 (dd, J = 6.2, 2.3 Hz, 0.18H), 5.02−4.96
(m, 2.72H), 4.14 (hept, J = 6.5 Hz, 2H), 4.06 (dt, J = 5.3, 1.9 Hz, 1H),
4.03−4.00 (m, 1H), 3.99−3.96 (m, 1H), 3.93 (dt, J = 11.1, 1.6 Hz,
1H), 3.78 (q, J = 6.1 Hz, 0.18H), 3.75 (q, J = 6.1 Hz, 0.82H), 3.54 (t, J
= 9.7 Hz, 0.20H), 3.52 (t, J = 9.7 Hz, 0.80H), 3.26 (ddd, J = 16.3, 8.3,
2.1 Hz, 1H), 2.94 (hept, J = 6.8 Hz, 1H), 2.80 (ddd, J = 15.1, 4.8, 1.5
Hz, 1H), 2.64 (ddt, J = 16.2, 5.3, 1.0 Hz, 1H), 2.35 (ddd, J = 15.1,
10.4, 2.9 Hz, 1H), 2.33 (d, J = 2.2 Hz, 0.79H), 2.30 (d, J = 2.2 Hz,
0.18H), 2.17 (dt, J = 14.3, 11.1 Hz, 1H), 1.70−1.61 (m, 1H), 1.50 (d, J
= 6.1 Hz, 0.54H), 1.45 (d, J = 6.1 Hz, 2.55H), 1.33−1.26 (m, 18H);
13C{1H} NMR (101 MHz, CDCl3) δ 156.0, 150.9, 123.7, 110.0, 85.9,
85.3, 84.4, 83.8, 77.2, 76.3, 71.6, 63.3, 63.0, 62.9, 60.7, 45.5, 40.2, 34.6,
34.3, 33.2, 24.8, 24.7, 23.6, 21.5. LiBr (25 mg, 0.29 mmol) and CuBr
(42 mg, 0.29 mmol) were dissolved in CH2Cl2 (1.0 mL). The mixture
was stirred at room temperature for 1 h, during which time the salts
dissolved and turned bright green. To a stirred solution of the above
trisylate (3.0 mg, 0.0043 mmol, 4.5:1) in CH2Cl2 (100 μL) was added
the LiCuBr2 solution (80 μL, 0.29 M, 0.023 mmol). The green
solution was stirred for 1 h at room temperature then heated to 60 °C
for 2 h until TLC (n-hexane/EtOAc 2:1) showed completion of the
reaction. The solution was passed through a plug of silica, eluting with
n-hexane/EtOAc 2:1. The solvent was removed in vacuo to give title
compound 6 (2.0 mg, 0.0040 mmol, 93%, 4.5:1 dr) as a white solid: Rf
0.63 (n-hexane/EtOAc 2:1); 1H NMR (400 MHz, CDCl3) δ 6.10 (dd,
J = 5.7, 2.2 Hz, 0.11H), 6.07 (dd, J = 5.7, 2.1 Hz, 0.52H), 5.43 (t, J =
5.5 Hz, 0.61H), 5.38 (t, J = 5.3 Hz, 0.15H), 5.01 (d, J = 7.7 Hz, 1H),
4.96 (dd, J = 4.3, 3.0 Hz, 1H), 4.35 (ddt, J = 11.2, 5.5, 2.1 Hz, 1H),
4.06 (dt, J = 5.2, 1.9 Hz, 1H), 3.97 (dd, J = 10.3, 9.8, 1.2 Hz, 1H), 3.93
(dt, J = 11.0, 1.9 Hz, 1H), 3.75 (dq, J = 9.8, 6.1 Hz, 1H), 3.51 (t, J =
9.7 Hz, 1H), 3.25 (ddd, J = 16.4, 7.9, 2.0 Hz, 1H), 2.79 (ddd, J = 15.2,
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4.5, 1.3 Hz, 1H), 2.62 (ddt, J = 16.3, 5.6, 1.1 Hz, 1H), 2.35 (ddd, J =
15.2, 10.4, 3.3 Hz, 1H), 2.18 (dt, J = 14.5, 11.1 Hz, 1H), 1.52−1.48
(m, 1H), 1.47 (d, J = 6.2 Hz, 0.57H), 1.46 (d, J = 6.1 Hz, 2.51H);
13C{1H} NMR (126 MHz, CDCl3) δ 200.9, 102.7, 86.1, 85.0, 84.3,
81.1, 74.3, 63.4, 63.0, 62.9, 60.1, 45.2, 44.1, 38.3, 22.4; HRMS (ES+,
TOF) m/z [M − Cl]+ calcd for C15H19O235Cl279Br2 458.9129, found
458.9131. The bromoallene dr was established by integration of the C1
proton resonances at 6.10 ppm (minor) and 6.07 ppm (major). 10% of
the mixture consisted also of inseparable propargylic bromides in a 1:1
ratio as calculated by integration of their terminal alkyne protons. The
observable peaks are given here: 1H NMR (400 MHz, CDCl3) δ 2.70
(d, J = 2.5 Hz, 0.05H), 2.68 (d, J = 2.4 Hz, 0.05H).
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